Precipitating auto-antibodies in the serum of patients with connective tissue diseases by Gray, K. G
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
PHBCÏPÏTATIHG AOTO-ARTIBODISS IH THK SERUM OF PATIENTS
WITH CONNECTIVE TISSUE DISEASES
ProQuest Number: 10647804
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uesL
ProQuest 10647804
Published by ProQuest LLO (2017). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
LIST OF GOm'Bm'S
Introduction,
Personal Inve sti gat1ons. 
Section I.
Page
14
Section II.
Teste for precipitating antibodies to 
salivary and lacrimal gland extracts in 
the serum of patients ’/?ith Sjogren* s 
syndrom©.
Reactions of a precipitating serum (Tra) 
tfdtb extracts of various tissues and 
blood constituents.
Quantitative precipitin curve for serum
Im.
Fractionation of tissues to determine tbo 
sito of tbo antigen reacting with sei^m T^.
Gomplemsnt fixation tests x^ ith senm Tra.
Further tests for precipitating antibodies 
to human tissue extracts in the serum of 
48 patients id.tb Sjogren’s syndrome.
Reactions of a second precipitating factor 
found in serum from patients with Sjogren’s 
syndrome as typified by serum Don ("anti- 
8jD").
Complement fixation tests with sorum from 
patients with Sjogren’s syndrome.
Discussion,
Serum precipitating factors in connective 
tissue diseases.
Serum precipitating factors in systemic 
lupus eryth emat osus,
I* Sorum Dun (**anti-Lup**),
II, Serum McL ( **anti-McL” ),
16
17
43
51
54
62
67
69
76
76
lyiy
87
Page
III. Serum MoDpu and serum Tan (antl-Dm% 95
Serum precipitating factors in the serm 
of 16 other patients with systemic lupus 
erythematosus. 102
Precipitating factors in the serum of 
patients with oonneotlve tissue diseases 
other than Sjogren’s syndrome and systemic 
lupus erythematosus. 105
Precipitin reactions between the serum of
patients with connective tissue diseases
and purified thyroglobulin. 108
Bi scussl on. Ill
Section III Antibody to tViyroglolmlin In th© serum of 
126 patients with connective tissue 
diseases. 117
Discussion. 124
General Discussion. 126
Materials and Methods. 141
Serum 141
Tissue extracts 141
Leucocyte extracts M 2
Precipitin tests 142
Imnmnoelectr oph oresl s 147
Goraplement fixation test M 9
Tanned red cell agglutination technique 152
Inhibition of tanned red cell agglutination 155
Preparation of radioactive labelled )
antigen or antibody 157
INTRODUCTION
INTRODUCTION
lb© applications of the principles of immunity^ the defence 
mechanism whereby an individual responds to the invasion of pathogenic 
bacteria, have been practised since the end of the eighteenth century.
The response to this invasion has been shown to include the development 
of antibodies to these bacteria. These antibodies, which may frequently 
be detected by various techniques, in the serum of th© individual, react 
with the pathogenic bacteria or their toxic products either to diminish 
their harmful effects or to participate in their destruction.
Hot only have antibodies been shown to ba produced against pathogenic 
bacteria, W t  the parenteral introduction of various substances, 
particularly proteins, into an individual may give rise to antibodies 
which react specifically with the substance introduced, This immunity 
mechanism has long been known to be able to distinguish between normal 
body constituenta and foreign or heterologous material. Thus in 
immunologieal experiments in goats Bhrlich and Morgenroth (1900) found 
that the injection of red blood cells from one goat into another would 
give rise to antibodies causing lysis of the red cells of the donor and 
certain other goats, but not of the recipient’s red cells « accordingly 
they formulated the principle of T^cxri'p]? ji%dbi3t(23dLcaia, This stated that 
no individual could react to produce antibodies to his own normal body
-  2 -
constituents and they believed that the formation of such tissue 
autowintlbodios would constitute a greater danger to the individual 
than any exogenous injury,
Bîvidence for the occurrence of auto-antibodies has, however, 
accumulated, showing that exceptions to the principle of horror 
aptotoxlcuB are encountered. Thus Donath and L-andsteiner (1984) 
demonstrated, in paroxysmal cold haomoglobinui’ia, a baemolysln which 
bad the character of an immune body which was activated by cold to unite 
with the patient’s own red blood cells but at internal body temperature 
of 37% behaved as an autohaemolysln owing to union with complement. 
Later, Midal, Abrami and Binale^  (1908), Chauffard and Troisier (1908) 
and Chauffard and Vincent (1909) observed autoagglutinins and 
autohaemolysins active at 37%^ in other types of haemolytie anaemia.
Subsequently many workers demonstrated haemolytie anaemia 
occurring in animals Injected with anti-red blood cell serum produced in 
a different species. Among these, Dameshek and Schwartz (1938) 
produced haemolytie anaemia experimentally in gu.inea pigs by injection 
of the serum of rabbits which had been immunized against gu.inea pig red 
blood cells. These authors concluded, however, from comparison of their 
experimental work with certain types of naturally-occurring haomolytic
i
anaemia in man, that the latter were oaueed by auto-antibodies which 
had been adsorbed on to the red cells. The description of the anti- 
globulin reaction (Coombs teat) by Coombs, Mourant and Race (1945? 1946), 
permitted further advances to be made in the study of antibodies to red 
cells, Boorman, Dodd and Loutlt (1946) applied the direct Coombs tost 
in five cases of acquired haemolytie anaemia and showed in-vivo 
sensitization of the patients' red calls by a gamma-globulin component 
of human serum and from these facts they reasoned that the acquired form 
of haemolytie anaemia was due to auto-antibody formation, Wiener, 
Battey, Claghorn, Maroon and Moynell (1953^ detected, in the. serum of a 
patient with haemolytie anaemia, an antibody which was directed against 
a single antigen on the patient's erythrocytes and failed to react with 
other human red blood cells which lacked this blood group factor. It 
has since been shown that antibodies occurring in the serum in acquired 
haemolytie anaemia are frequently directed specifically against one or 
more of the patient*a own erythrocyte 'isoantigens'. The experimental 
production of auto-antibodies to red cells In animals has not yet been 
achieved, Bielchowsky, Belyer and Howl© (1959) have reported in a 
strain of inbred mice a naturally-occurring haemolytie anaemia in which 
the erythrocytes were found to be coated with go.rmna-globu.liri and 
evidence that this was an auto-immune condition was confirmed by Holme a.
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Gorrie and Burnet (1961), w' o transmitted tbs disease from affected 
adult mice to normal young mica of the same strain by transfer of 
splenic cells.
Autoantibodles in man have also been demonstrated to leucocytes 
and platelets. The demonstration of these antibodies is technically 
more difficult than the detection of antibodies to red cells, for which 
many reliable techniques have been elaborated. Walford (i960) reviewed 
many reports of the detection of leucocyte auto-agglutinins and 
dismissed a number of these on the grounds that there was insufficient 
evidence that auto- rather than iso-immunization bad occurred. Killmann 
(1957) first put forxvtard the clearest evidence for the occurrence of 
leucocyte auto-agglutinins in a patient witli acute monocytic leukaemia 
and subsequently there have been several convincing reports. Auto- 
antibodies to platelets have been demonstrated In serum from patients 
with idiopathic thrombocytopenic purpura by Harrington, Sprague, Mlnnloh, 
Moore, Aulvln and Dubaoh (1953) and by Stofanlnl, Plitman, Dameshek, 
ChatterJaa and Medniooff (1953)«
In recent years, various diseases have been produced experimentally 
in animals injected with tissue extracts or other tissue constituents 
incorporated into Freund’s adjuvant (Freund and McDermott, 1942), Several
groups of workers have used either the animal’s own individual 
(1 + 0* autologou©) tissue, or tissues from other animals of the same 
species (homologous tissues), and have injected them into subcutaneous, 
intradermal or Intramus'cular sites* By this technique, lesions have 
been produced In the tissue or organ corresponding to that injected.
Both the clinical and histological features of these diseases have, in 
some cases, borne such close similarities to certain naturally- 
occurring human diseases that an immmiological mechanism has been 
postulated as the cause of the disease in man. In 1949, Rabat, Wolf 
and Bezer described the prorhiotion of disseminated encephalomyelitis in 
rhesus monkeys by injection with autologous tissue Incorporated in 
Freund's adjuvant : comparisons were drawn between this experimental
disease and acute demyelinating encephalitis occurring naturally in man 
and occasionally in individuals who have received a scries of injections 
of rabies vaccine which consists of a saline suspension of brain or 
desiccated spinal cords of Infected rabbits, Bye lesions, both of the 
lens (Müller, 1952) and the uveal tract (Collins, 1949), and lesions of 
the testis (Freund, Dipton and Thomson, 1953), peripheral nervous system 
(VJaksman and Adams, 1955), thyroid (Wlteba% and Bose, 1956) and adrenal 
(Oolover and Glynn, 1958) have all been induced experimentally in animals 
by injection of the corresponding, homologous antigen. Accordingly, 
diseases in which comparable lesions in the corresponding human organ occur
have been attributed somowhat speculatively to an auto-imiriune machaniem,
Tbo occurrence of auto-antibcd1ee to tissue cells and constituents 
is, in general, difficult to prove. Claims, in recent years, to have 
demonstrated auto-antibodies which reacted with various human tissues 
remain, in many cases, unsubstantiated. In some.of these accounts there 
is no convincing ovildenee that the reactions concerned are of an 
immunological nature. In other reports, antibodies have been demonstrated, 
but it has not been possible to use the patient’s own tissue antigens for 
the investigation and consequently it is not known whether the antibodies 
developed as a result of auto-immunlzation or whether they indicate only 
that iso-immunlaation has occurred. Of the various tissues against which 
auto-antibodies have been claimed to develop, evidence is most strong for 
the thyroid gland.
The interest in the occurrence of auto-immunity in thyroid disease 
was aroused by two almost simultaneous reports, the first on the 
experimental work in rabbits reported by Mltebsl^ y and Hose (1956) and 
the second on the serological investigations in naturally-occurring human 
chronic thyroiditis carried out by Roitt, Doniaoh, Campbell and Hudson 
(1956).
Wltebsliy and Rose doacrlbeU the production in rabbits of antibody
to rabbit thyroglobulin# The animals wore injected intradermally 
with a crude saline extract of rabbit thyroid gland, or with, "purified" 
rabbit thyroglobulin, incorporated into Freund’s adjuvant, the purpose 
of the adjuvant being to increase the ismiune reaction. Following these 
injections, antibody to thyroglobulin was demonstrated in the serum of 
some of the animals by various techniques, including complement fixation, 
precipitation, and the tanned red cell agglutination technique of Boydon 
(1951). Since the antibody to thyroglobulin reacted with th© autologous 
(i*e, the injected animal’s ox^ n) thyroid tissue extract and since 
injection of the autologous thyroglobulin stimulated th© development of 
tbo antibody, these experiments provided good evidence that auto- 
immunization had been effected. In some of the animals the production 
of antibody xms accompanied by the development of chronic inflammation in 
the animal’s own thyroid gland, these appearances being regarded as 
similar to naturally-occurring human chronic thyroiditis,
Evidence that auto-immunizatlon plays a part in human chronic 
thyroiditis was provided by Roitt, Doniach, Campbell and Hudson in 1956, 
Serum from patients with Hasbimoto’s thyroiditis had previously been 
shown to contain high levels of gamma-globulin and to give abnormal 
reactions in serum-flocculation tests (Luxton and Cooke, 1956), This 
led Roitt and his colleagues to postulate that antibodies were being 
produced against the thyroid, and they succeeded in shox%ring that
8precipitating antibodies, wbioh reacted with saline extracts of human 
thyroid tissue and with "pirified" human thyroglobulin, occurred in the 
serum of patients with Hashimoto’s thyroiditis*
There have since been found other types of circulating antibody In 
patients with varying degrees of chronic thyroiditis, The precipitin test* 
which was used at first by Roitt at al,, has boon shown to be positive only 
in patients with severe chronic thyroiditis. In Hasbimoto’s thyroiditis, 
the serum of about ?(% of patients gives a positive precipitin result ? in 
primary hypothyroidism* in which the thyroiditis is less florid than In 
Hashimoto’s thyroiditis* about U S  of prbients are positive. In 
patients with other thyroid diseases* such as thyrotoxicoais* the 
precipitin teat is negative unless thyrotoxicosis lo accompanied by 
severe chronic thyroiditis. The fluorescent antibody technique of Coons* 
Creech * Jonas and Berliner (1942) has been applied in thyroid disease and 
precipitin positive sera have been shown to stain the thyroglobalin- 
containing colloid in frozen sections of thyroid gland (White* 1957).
Other, more sensitive techniques have been used to demonstrate 
antibody to thyroglobulin in human thyroid disease. The latex fixation 
test (developed by Hyland Laboratories * Los Angeles) is slightly more 
sensitive than the precipitin tost (Anderson, Buchanan, Ooudie and Gray) 
1962)1 the tanned red cell agglutination method (Roitt and Donlaoh*
I95B) is extremely sensitive and demonstrates thyroglobulin antibodies
9'*-‘7 «se*
not only in severe chronic thyroiditis* where these antibodies are 
generally present in high titres, but also in other thyroid diseases 
where there is often only a slight degree of thyroiditis accompanied by 
low concentrations of the antibody. Complement fixation tests* using 
as antigen extracts of thyrotoxic tissue* have demonstrated the presence 
of a second antibody to thyroid tissue which reacts with an antigen 
present in the microsomal fraction of thyroid epithelial cells and 
particularly abundant In extracts of thyrotoxic glands (Belyavin and 
Trotter* 1959)* Pulvertaft* Doniach* Roitt and Hudson (1959) and Irvine
(i960) reported a semm factos:** in patients with chronic thyroiditis* which 
is cytotoxic to trypsinised thyroid epithelial cells grown in tissue 
culture, Goudie and McOallim (1962) have provided evidence that this 
factor is an antibody and that* like the thyrotoxic complemont-fixing 
antibody, it reacts with thyroid epithelial mioroaOBies and requires the 
prc3sonco of complement for its cytotoxic action. Another thyroid 
antibody, demonstrable by the fluorescent antibody technique and reacting 
with a constituent of the thyroid other than thyroglobulin* has been 
reported ty Balfour, Ooniaoh, Roitt and Qouchman (I96I),
Witebsky’s production of experimental auto-immune thyroiditis in 
animals, taken together with the demonstration of various circulating 
antibodies to thyroid in patients with chronic thyroiditis, strongly 
suggests that auto-immunization may be the cause of thyroiditis in man.
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HowevoT* none of the various antibodios in the human disease correlates 
closely with the extent of chronic thyroiditis* and none of them has been 
shown to be the agent responsible for destructive changes in the thyroid 
gland. It be that this agent is a coll-bound antibody of the type 
which causes a delayed hypersensitivity reaction, Mitebsky, Rose and 
iShulinan (1956) carried out skin tests with thyroid extracts in auto- 
immunized rabbits and demonstrated a reaction of the delayed type. Skin 
tests in man were also carried out by Buchanan* Anderson, Goudie and Gray 
(195s)* but the reaction observed was believed to be a delayed Arthus 
phenomenon. The results of both these groups of workers could be 
attributed to circulating* rather than coll-bound, antibodies? true 
delayed hypersensitivity would be difficult to demonstrate as it would 
tend to be obscured as a result of the initial reaction duo to circulating 
antibodies. Passive transfer of immune seinjm has been unsuccessful in 
producing auto-immun© thyrolditie (Roitt and Doniach * 1958) but recently 
Felix“Davies and Haksman (1961) have reported that transfer of lymph 
nodes or splenic cells from guinea pigs immunized against thyroid tissue 
has produced experimental thyroiditis in the recipient guinea pigs. It 
therefore appears that the destructive agent In experimental thyroiditis 
is a cell-bound* rather than a circulating antibody and it is possible 
that this may also bo true for human chronic thyroiditis.
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Evidence for auto-antibcdies occurring in other diseases bag also 
been strengthened in recent years. In patients with idiopathic Addison's 
disease antibodies to adrenal tissue have boon demonstrated by complement 
fixation and. fluorescent antibody tests (Anderson* Goudie, Gray and 
Timbury* 1957* Blizzard * Chaiodler, Kyle and Hung* 19^2), Antibodies 
to colon have been demonstrated in serum from patients with ulcerative 
colitis (Broberger and Porlmann, 1959) and in serum from patients with 
pernicious anaemia antibodies have been demonstrated reacting with extracts 
of gastric mucosa (Irvine, Davies* Delamore and Williams* 19^2* Taylor, 
Roitt, Doniach* Qouchman and Shapland, 1*^2, Marks on and Moore, I962),
Immunological associations of Sjogren’s syndrome 
The appearance of the thyroid in Hashimoto’s thyroiditis is one of 
extensive infiltration by lymphocytes and plasma cells, associated with 
large, eosinophilic epithelial cells, forming small thyroid follicles, or 
arranged in small groups with no remaining follicular structure, Gardell 
and Curling (1954), reviewing three cases of Sjogren’s syndrome, 
characterized by degenerative and atrophic changes in the lacrimal and 
salivary glands and accompanied by decreased secretion of these glands, 
were struck by the resemblance of these lesions to those occurring in the 
thyroid gland in Hashimoto's thyroiditis and in primary hypothyroidism.
The resemblance between Haahlmoto’a thyroiditis and Sjogren’s syndrome was
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further emphasized by Heaton (1959), who stated that the two have in 
common age and sex Incidence, raised erythrocyte sedimentation rate, 
increased gamma-globuHns, and abnormal thyniol-ttirbidity teats; as a 
result of these associations, h@ postulated that Sjogren’s syndrome also 
bàd an auto-immune basis, Jones (1958) examined serujn from 40 patients 
with Bjëgren’s syndrome and reported that there was in one patient a 
serum precipitating factor which reacted with extracts of human salivary 
and lacrimal glands and also with some extracts of Icidney tissue ; he 
also stated that the serum garnma-globulins were raised in this patient 
but did not state whether the precipitating factor was In the gamma­
globulin serum fraction and therefore likely to be an immune antibody.
The frequent occurrence of various degrees of thyroiditis in 
Bjdgren'e syndrom© has been referred to by Heaton (1959)g and Bunim
(1961), in a review of 40 cases of Sjogren’s syndrome, detected antibodies 
to thyroglobulin in eleven.
In addition to its similarities to and associations with chronic 
thyroiditis, Sjogren’s syndrome is also associated with the group of 
conditions termed "diffuse collagen diseases" by Klemperer, Pollack and 
Baahr (1942) and now more widely termed "connective tissue diseases," 
Included in this group of conditions are rheumatoid arthritis, systemic 
lupus erythematosus, chronic discoid lupus erythematosus, progressive 
systemic sclerosis, dermatomyositl8 and polyarteritis nodosa. The
•* X3
commonest association between Sjogren'a syndrome and the connective 
tissue diseases Is provided by the high incidence of rheumatoid 
arthritis in patients with Sjogren’s syndrome. Heaton (1959) reviewed 
a series of twenty-eight patients with Sjogren’s syndrome and described 
many clinical and pathological features commonly observed in systemic 
lupus erythematosus* The association of SjGgren’s syndrome with 
ayatomic lupus erythematosus and with progressive system sclerosis has 
been noted in several recent reports, e.g. Bunim, I96I, Shearn, I96O, X96I.
PERSOKAI. INVESTI GATIONS
In view of tbo above features and associations of Bjëgran’a 
syndrome, the serum of patients with this condition was tested for 
the presence of auto-antIbodlea. From the work of Jones (195B),
referred to above, and from analogy with Hashimoto’s thyroiditis, it 
was anticipated that auto-antibodies reacting specifically with salivary 
and lacrimal tissues might bo detectable. This expectation was not 
fulfilled, since, although auto-antlbodles were detected in SjHgren’a 
sera, they reacted not only with extracts of lacrimal and salivary 
tissue but also with various other tissue extracts.
As a result of these findings, serum was also examined from patients 
with other connective tissue diseases, using the same technlgms, and In 
addition to the auto-antibodies previously demonstrated in SjGgren’s sera, 
other antibodies ware also detected. In addition to these investigations, 
the associations between chronic thyroiditis, Sjogren’s syndrome and the 
connective tissue diseases led to the examination of the serum of 
patients with the latter two types of disease for antibodies to 
thyroglobulin, using a sensitive teahni.que. The work to be described 
thus falls into three sections.
Section I. Serum from patients with SjBgron’s syndrome was examined 
for antibodies reacting with human lacrimal and salivary tissue extracts. 
Section.II. The serum of patients with other connective tissue diseases,
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including systemic lupus erythematosus* chronic discoid lupus 
erythematosus* progressive systemic sclerosis, dermatomyosltls, 
rheumatoid arthritis and polyarteritis nodosa was examined for 
antibodies reacting with extracts of a wide variety of human tissues 
and organa.
Section III. The incidence of antibodies to thyroglobulin. as detected 
by the tanned cell agglutination technique, was estimated in the serum 
of patients with connective tissue diseases, including Sjogren’s 
syndrome.
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SBCTIOH I
TESTS FOR PRECIPITATING ANTIBODIES TO SALIVARY AND UCPIMAL GLAND
OF PATIENTS WITH SJOGREN'S SÎTORO»®
The method used by Jones (1958) to demonstrate a precipitating 
factor in Sjogren sera was a modification of the technique of 
Oucbterlony (1953) in which immune semm and antigen are placed in the 
wells in an agar plate and the precipitating antibody and antigen diffuse 
into the intervening agar, where they react to form a visible precipitate, 
Jones used a sloppy agar and an elaborate arrangement of troughs in the 
agar; troughs containing the undiluted teat sera were refilled as it 
was found that the serum factor (? antibody) was weak. On the other 
hand, the tissues were extracted with 2 or 5 volumes of saline solution 
and it was not considered necessary to refill the troughs containing the 
extracts, sugg^esting that the tissue precipitating factor {? antigen) 
concerned was relatively abundant.
In an attempt to repeat Jones' observations, serum was obtained 
initially from 2 cases of Sjogren’s syndrome and was tested in agar-gel 
diffusion plates using, as antigen, extracts of human salivary or 
lacrimal tissue* In the light of previous experience of precipitation 
reactions involving antibody to thyroglobulin, a somewhat different 
modification of the Ouehterlony technique was adopted (see p. 143) in 
preference to that used by Jones. Initially, a $(% extract of parotid
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gland in 0,9 % saline solution (p.141) was ugocl both undiluted, and at 
a dilution of 1 in 4, whereas the serum was used undiluted. In addition 
to the 2 specimens of Sjogren senm, 5 control sera, obtained from 
patients with other conditions, were also tested with both concentrations 
of parotid gland extract, These tests were examined daily» after 2 
days a band of precipitate was observed between two of the wells, one of 
which contained undiluted parotid extract and the other contained a serum 
from a patient (Tra) with Sjogren’s syndrome (Fig, 1 ), T’is precipitate 
was situated very close to the well containing the tissue extract. The 
other sera did, not react to form a precipitate over a period of several 
days.
This encouraging result, which ah wed the presence in serum Tra of 
a factor which reacted with a constituent of salivary gland extract to 
produce a precipitate, led to this serum being singled out for further 
investigation.
Reactions of ae]smJf^Hltb.-..eAant.g.. .o£.JgirioBa
Various tissue extracts, including lacrimal gland, 3 parotid glands, 
4 submandibular glands, 2 thyrotoxic thyroids, Iddnoy, liver, adrenal and 
normal thyroid, were tested in Ouehterlony agar-gel diffusion plates 
around undiluted scrum Tra, All these tissue extracts appeared to 
react to form a precipitate with serum Tra although In many cases a very
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dense zone of opacity, or halo* round the welle containing the tissue 
extract, made the band of precipitate rather difficult to discern,
(Fig, 2 ), à positiva result with serum Tra was also obtained with 
extracts of brain (both white and grey matter), spleen and testis. 
Thyrotoxic thyroid extract appeared to give the most distinct band of 
precipitate and the least opacity around the tiesue extract well,
Jones had described opacity occurring around the serum well in his 
Ouehterlony tests and had found that the method described by Halbert, 
Swlok and Bonn (1955) of incorporating glycine into buffered agar 
diminished this effect, I prepared glycine-buffered agar, as Jones had 
clone, in order to try to minimize the haloes around the wells containing 
the tissue extracts. This mad© no difference, however, the haloes 
around the wells In the buffered glycine-saline agar being as dense as 
those in plates containing azide-saline agar*
A series of fourfold dilutions of serum Tra in 0*9 saline solution 
was tested with a thyrotoxic thyroid gland extract, used undiluted • a 
precipitate was observed up to a dilution of 1 in 256 of serum Tra. With 
undiluted thyrotoxic thyroid gland extract, serum Tra gave distinct, 
straight lines of precipitate at all dilutions from 1 in 1 to 1 In 25&. 
The position of the precipitate vajriad from vary close to the tissue 
extract well with undiluted serum, to a position which was slightly
nearer th© serum well than th© tissue extract well with the higher 
dilutions (Pigs. 3a and 3b). Th© optimal dilutions of serum Tra 
(i.e. the dilations at which the bands of precipitate were most sharply 
defined and approximately mid-way between the wella) were between 1 In 
l6 and 1 in 64. Therefore In most of the agar-gel diffusion teste 
performed subsequently with serum Tra* the dilution used wag 1 in 32.
In further tests* in which various sizes of wells were spaced at 
various distances from each other, it was found that wells of 10 mm, 
diameter, with their centras 15 mm. apart, gave optimal precipitation.
The incidence of the precipitating factor reacting with sarum Tra in 
TOxlpaa tl.8m9a....and .
Tissues obtained post-mortem from one individual, including liver, 
kidney, adrenal* submandibular and thyroid gland* were extracted and 
tested against dilutions of serum Tra and dilutions of a control 
(Hashimoto) serum containing precipitating antibody to thyroglobulin? 
serum Tra reacted up to a dilution of 1 in 256 with every extract, 
whereas the control seium was negative with all except thyroid extract. 
Suspensions of whole blood, washed red blood celle (lyseci by repeated 
freezing and thawing), platelets, serum and pooled gamma-globulin 
prepared by the Scottish National Blocx] Transfusion Association* were 
tested in various dilutions with a 1 in 32 dilution of serum Tra ? no 
precipitation was observed in any of these tests. ’4hen leucocyte
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©xtracfts were tested with serum Tm, variable results were obtained* 
Leucooyte extracts from normal individuals and from patients with chroyiic 
myeloid leukaemia failed to give a precipitate with serum Hi3 s but 
leucocyte extracts from patients with lymphatic leukaemia gave a 
positive result* This finding with leucocytes from different sources 
will to© discussed more fully on p. 27, Tissues of low cellular!ty, 
such aa joint fluid^ costal cartilage, skeletal and heart muscle and 
umbilical cord, were also tested with serum Tra« no precipitation was 
detected with any of these tissues* Skin fItoroblasta, (maintained for 
7 months in tissue culture and kindly supplied by the Department of 
Genetics, Glasgow University) were obtained from 4 individuals and 
extracted % all 4 extracts were negative with serum Tra* Extracts of 
pooled spermatozoa from several individuals were also negative. Saliva 
and tears, the secretion of which is considerably reduced in Sjogren^s 
syndrome, were obtained from blood group 0 individuals, tested 
unooncentrated with serum Tv§ and found to be negative* A solution of 
tbyroglolmlin (5 rng/ce) prepared by the method of Derrien, Michel and 
Roche (1948) and shown to react with a serum containing antibody to 
thyroglobulin^ failed to react to form a precipitate with serum Tra.
The precipitating factor in serum Tra is therefore not anti-thyroglolmlin*
21 -
When dilutions of tissue extracts ware titrated with serum Tra.iFoesTwew 7
diluted 1 in 32, the highest dilution which produced a precipitate wag 
1 in 8, and this was exceptional. Most tissue extracts reacted only 
when undiluted, or when diluted 1 in 2 or 1 in 4.
Immunoelectrophoresis of serum fra was carried
out in agar aa described on p* 14?. Thia showed that the precipitating 
factor in serum had the electrophoretic mobility and pattern of gamma* 
globulin (Fig, 4 )*
tatlon. k quantity of serum Tra was sent to Dr, F,â,
Gharlwood (of the National Institute for Medical Research, Millhlll,
London) who Idnclly carried out ultracentrifugation of the serum. The 
method used was a modification of the sucrose density-gradient method in 
which radioactive-labelled gamma-globulin of known sedimentation constant 
was added to serum Tra to act as a tracer. The fractions of serum Tra 
provided by Dr, Charlwood were tasted in agar-gel diffusion tests and 
the precipitating factor in serum Tra was found to be present only in the 
fractions containing the 7S-gamma-globulin fraction of the serum.
The results obtained by immunoeleetrophoraals and ultracentrifugation 
of serum Tra provide good evidence that the serum factor which is concerned
Is an antibody.
Direct teats tm
Human tissue extracts reacting with serum Tra were compared by 
moans of the Oucbterlooy agar-gel diffusion test for Identity of 
antigen-antibody systems. Pairs of extracts ware compared by placing 
them in 10 mm# diameter wells situated with edges 3 mm. apart, and serum 
Tra was placed in a well of 6 mm# in diameter as shown in Pig# 5. As 
this last well was smaller than that previously shown to give optimal 
precipitation with a 1 in 32 dilution of serum Tra, this was compensated 
for l^y using serum at a dilution of 1 In 10 in this experiment# The 
arrangement of the wells was such that the factors present in the extracts 
under comparison would react with serum T%%a,. to form precipitates which 
would meet each other, either to fuse completely, indicating a "reaction 
of identity" of the tissue antigens or to cross each other, suggesting a 
"reaction of non-^identity" or to fuse partially with spur formation 
indicating a "reaction of partial identity" of the tissue precipitating 
factors# These patterns of precipitation, described by Ouehterlony 
(1953); have been shown to be considerably altered by variations in 
concentrations of the reagents (Korngold, 1956, MiIson and Pringle, 1956), 
However, when extracts of liver, kidney, adrenal, submandibular and 
thyroid gland from, one individual, all shown to give a distinct
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precipitate with serum Tra., were set up in pairs, kidney with liver, 
kidney with thyroid, thyroid with submandihular, etc*, all these organ 
extracts were observed to give lines of precipitate which fused 
completely with each other, indicating "complete Identity" of the tissue 
precipitating factors* Extracts of human tissues from other incllvlduals 
also gave reactions of Identity with this set of extracts* Extracts of 
lymphatic leukaemic leucocytes alao gave reactions of complete Identity 
with these organ extracts.
It is thus concluded that the reactions of serum Tra with a wide 
variety of human tissue extracts are due to a single tissue antigen 
present in all the extracts* This antigen is also present in extracts 
of lymphatic leukaemlo leucocytes and is therefore regarded as a cellular 
constituent* Because It reacted well with eerum Tra.Ravo minimum halo- 
effect, and was readily obtainable in the fresh state, thyrotoxic thyroid 
tissue was used subsequently, except when otherwise stated, In tests with 
serum Tra*
wltb tlamw The preTrloas section, reporting the reactions of
identity of tissue extracts, provides a means of comparing the precipitating 
factor in the extracts. Another method by which the extracts may be 
compared is by treating serum Tra. with a relatively large volume of a
tiaau© extract and testing the resulting product for precipitating 
antibody with various tissue extracts, including the one used for 
absorption* If the antibody in the mixture has been annulled by the 
tissue extract, it would not be expected to form a precipitate with the 
extract used to annul it, or with any other tissue extract containing 
the same tissue antigen
Accordingly, a mixture was prepared containing one part of serum Tga 
and fifteen parts of thyroid extract. Similar mixtures of serum Tra 
with extracts of liver, kidney, adrenal and parotid gland were prepared, 
and all were kept overnight at 4^G.to allow antigen-antibody reaction to 
occur. The following day, each mixture was tested in an Ouehterlony 
agar-gal diffusion plate with each of the tissue extracts and also wdth 
serum Tra* All the mixtures of serum Tra with tissue extract reacted, 
with the various tissue extracts including the extract used to annul the 
eerum# The same mixtures, however, f^^ th suitable
dilutions of serum Tra, It therefore appeared that in the mixtures the 
tissue extract antigens were annulled by serum Tra. Since annulment of 
the antibody in serum Tra by tissue extract antigens bad not been 
demonstrated, further experiments were performed in which serum Tra was 
mixed with greater volumes of tissue extract, but even when the final 
dilution of serum Tra in the mixture was 1 in 100. serum Tra continued 
to react to give a precipitate with some of the tissue extracts used for
absorption#
This attempt to annul serum Tya with tissu© extract in order to 
show tVf© identity of the precipitating factors in the tissue extracts 
was therefore unsuccessful# It showed, however, that the tissue 
extracts contained very low eoncontrationa of antigen relative to the 
amount of antlbofly in sermn Tra.
Serum Tra was mixed with tissue extract in the ratio of one part 
of serum to nine parts of extract. A normal aain?,m was mixed in the 
same proportions with the tissue extract, this mixture serving as control 
for the activity of the tissue precipitating factor. Both mixtures were 
left overnight at 4^0* and on the following day were tested in agar-gel 
diffusion plates with serum Tj?a (1 in 32), and with the tissue extract 
used for absorption* Tissue extracts which had been treated in this 
manner with serum Tra failed to form a précipitât© when tested with serum
Î precipitation was not inhibited by similarly treating the tissue 
extracts with normal serum. The mixtures containing serum Tra. 
continued to react with tiesuo extract to form a precipitate, showing 
that excess of antibody was present in the mixture. These results show 
that the antigenic constituent of tissue extracts which react with serum 
Tra is readily annulled by excess antibody, thus confirming that 
relatively small amounts of antigen are present in the extracts*
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Extracts prepared from animal tissues obtained immediately after 
death were tested in Ouehterlony plates with serum Tra (1 in 32)* 
Precipitates were observed with extracts of the livers, kidneys and 
spleens of guinea pigs, rabbits and mice. Tissue extracts from rats 
caused a particularly dense zone of opacity around the wells In which they 
were placed, but, with the exception of one extract of rat spleen, no 
precipitates were observed between these extracts and serum Tra. Similar 
dense zones of opacity were observed when tissue extracts from hen and 
trout organs were tested against serum Tra, and no precipitates could ba
detected. Normal human senm, tested at several dilutions, gave no
precipitates with any of these organs. Direct tests of identity were
carried out as described previously (p; , 22-23 ) and reactions of
identity for serum Tra were obtained between extracts of human and 
animal tissues.
least ribonucleic acid and deoxyribonucleic acid from calf thymus 
nuclei (Nutritional Bloehomicale Corporation), tested in a wide range of 
concentrations, failed to give a precipitate with serum Tra.
Effect of heat on antibody in serum Tra and on tis!
Seram Tra was îieated at 55^0, for 2 hours and was then tested with 
thyroid tissue extract. The précipitât© obtained had the same appearance
«• 2?  •*»
as with unheated serum. Only faint precipitation occurred, however, in 
tests with serum heated at 650O* for 30 minutes.
The precipitate between serum Tra and tissue extract heated at 45®C. 
for 30 minutes was much fainter than with unheated tissue extract and 
with tissue extract heated at 55^0.«for 30 minutes, no precipitate was 
obtained. Incubation of the tissue extract at 37^0. for about 6 hours 
also weakened its precipitating antigen.
An extract of thyrotoxic thyroid, buffered at pH 7.4? was treated 
with crystalline trypsin (British Drag Houses), at 37^0.for 2 hours*
This treatment was found to destroy the antigen for serum Tra.
Gryatalllne chymotrypsln, used at concentrations of 0.4# and papain at 
concentrations of 0.1 and 0.% also destroyed the antigen for serum Tra. 
0*4# diastase solution had no effect on the antigen. Deoxyribonuclease 
(Nutritional Bioohemloals Gor| oration) dissolved in phosphate buffer 
(pH 6.8), containing 5 uM MgOlg per ml., was added to thyrotoxic thyroid 
extract and the mixture was incubated for 1 hour at 37^0. as described by 
Deioher, Holman and Kunkel (1959)* This treatment had no effect on the 
antigen for serum T^: ribonuclease was also without effect on the
antigen.
As previously stated (p. 20 ), the tissue antigen was present in all
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extracts of lymphatic leulciemic leucocytes which were tested, but was 
not demonstrated in extracts of normal leucocytes or of leucocytes from 
patients with myeloid leukaemia. These results suggested that the 
myeloid leukaemia leucocytic extracts and the normal leucooytic extracts 
might contain a factor, possibly enzymic, which was responsible for the 
destruction of the antigen for serum Tra. Accordingly, equal volumes 
of thyrotoxic thyroid extract and myeloid leukaemia lauaocytic extract 
were incubated at 37^0, for 3 hours and then tested for antigen for serum 
Tra in an agar-gel diffusion test* Similar mixtures of thyroid and 
leucooytic extracts ware prepared and incubated, using an extract of 
normal leucocytes and an extract of lymphatic leukaemlc leucocytes* The 
results obtained showed that the antigen was destroyed by incubation with 
extracts of myeloid leukaemia or normal leucocytes, but that a precipitate 
was still obtained when the antigen was mixed and incubated with an extract 
of lymphatic leukaemio leucocytes* A control, consisting of thyrotoxic 
thyroid extract, diluted with an equal volume of saline solution and 
incubated at 37%.for 3 hours, still gave a precipitate with serum Tra.
This finding suggests that the inhibitory substance present in normal and 
myeloid leucocyte extracts is of an enzymic nature*
The quantitative characteristics of the precipitin reaction between
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serum Tra and the corresponding antigen were studied In the following 
series of experiments.
Principle. In a classical antlgen-antlbody precipitin curve, as des­
cribed by Heidalberger and Kendall (1935), precipitation occurs on 
addition of antigen to excess of antibody, the amount of precipitate 
depending on the amount of antigen present* thus, increasing the amounts 
of antigen added to a constant amount of antibody results in an increase 
in the amounts of precipitate formed, until a maximum is reached in the 
equivalence zone where neither antigen nor antibody is in excess. In 
the zone of antigen excess, soluble antlgen-antlbody complexes are formed 
and the amount of precipitate decreases in this region. Babbit 
antibodies regularly form this type of curve, whereas with certain horse 
antibodies, inhibition of precipitation occurs with antiborly excess as 
well as in the antigen excess zone.
JiaM- Ths antigen
used was a thyrotoxic thyroid gland extract. Both antigen and serum were 
centrifuged at 12,000 g. for 15 ralnutes to remove fine, particulate 
material and mixtures of the 2 reagents ware prepared in tubes 2 x 0,6 cm, 
as shown.
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Tube No. 1 2 3  4 5 6 7 8 9 10 11
Dilutions
of serum 1/1 1/2 I/4 l/g I/I6 1/32 I/6I 1/128 1/256 1/512 Hil
&Î. (3
drops per 
tube)
Thyroid
extract l/l l/l l/l l/l l/l l/l 1/1 1/1 l/l l/l l/l
(3 drops 
per tube )
A second row of tubes containing mixtures of undiluted thyroid extract 
and dilutions of a normal serum Instead of serum Tra, was prepared at the 
same time * To each tube was added on© drop of 1# a odium aside solution* 
to prevent bacterial contamination. Both rows of tubes were kept at room 
temperature during the day and at 4%* overnight. No visible precipitation 
had occurred after 24 hours. The small precipitates obtained after 72 
hours were washed 3 times with 0,9# saline solution at 4^G, and each was 
then dissolved in 0,1 M sodium carbonate solution. The amount of 
precipitated protein was so small that it was not possible to estimate it 
satisfactorily by measuring Its absorption of ultra-violet rays at a 
wavelength of 280 mu, on a llvlapak spectrophotometer.
This preliminary attempt to prepare a quantitative precipitin curve 
for serum Trq having been unsuccessful, it was not thought worthwhile to 
continue with this method using larger volumes of reagents. The following
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method,of obtaining a precipitin curve for serum Tra was therefore used.
2. Radloao-b.lve laballli^R.oCtMroW exteact. with loaine ( ^ %  ). labelling 
of protein with radioaotive Iodine ) provldea a sensitive technique
for tracing small amounts of the labelled reagent. It is normally a satis- 
factory technique for use in immunological reactions, little alteration 
in the immunological properties of certain protein antigens being observed 
after labelling with small amounts of Isotope, The method is essentially 
that described by Francis* Mulligan and Wormall (1954) and is given on 
P. 157.
15 ml, of a fresh, thyrotoxic thyroid gland extract was labelled by 
this procedure. On centrifugation of this extract at 34?000 g, for 1 hour 
after labelling, an appreciable deposit was formed, The aupernute was 
pipetted off and tasted for antigenicity in an agar-gel diffusion test. 
Seram Trq,. diluted 1 in 25, formed, a faint band of precipitate with this 
radioactive antigen, whereas the untreated extract had formed a well- 
defined precipitate. This result suggested that the antigen had bean 
weakened by the treatment and dilution occurring during the process of 
radioactive labelling. It was decided, nevertheless, to test this 
antigen in a fluid medium. Accordingly, 10 drops of the radioactive 
thyroid gland extract were mixed with 2 drops of serum Trag 10 drops of 
the thyroid gland extract were also mixed with 2 drops of a normal serum
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and both tubes were kept at 490. for 48 hours. The email amounts of 
precipitate obtained after the tubes bad been centrifuged at 1500 g. at 
4*^ 0, were washed 3 times at 490» with saline solution and re suspended in 
saline solution. The radioactivity present in the supernates* washings, 
and deposits was measured In a well-type scintillation counter, and the 
results are presented in Table 1,
These results show no significant difference in the radioactivity 
of the final deposits in the two tubes or in the washings. It was 
concluded that either radioactive labelling of the antigen for serum 
Tra had not been achieved or that the antigen bad been largely destroyed 
during the process of ^31| labelling. Deposition of radioactive 
material in the mixture containing normal serum suggests that some 
dénaturation had occurred. The next attempt was made with I31x 
labelled .mam#
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Supernate
First wash
Second wash 
" deposit
Third wash 
" deposit
TABLE 1
Serum T%% 
thyroid «* ‘^31 i 
Counts per 100 secs.
5Z)*mo
60,000
4 ; 34 2 
5,668
742
4*316
Normal serum -î- 
thyroid - ^31% 
Counts per 100 sees
520,500
52,000
5,668
7,113
710
5,994
* These résulta have been corrected by subtracting the counts 
per 100 seconds due to background.
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3. Radioactive latelllng„ of. gemm fra. Labelling with was
carried out on whole serum using the same method previously described 
for thyroid extract {p, 157 ). 10 ml. of serum Tra was used for this
purpose and 10 ml, of normal seram was labelled at the same time. The 
antigen used with the labalJled serum was a pooled extract of twenty 
thyroids. Both the labelled serum and the pooled thyroid extract were 
centrifuged at 34,000 g, for 30 minutes before use. 2 ml, amounts of 
dilutions of thyroid extract were mixed with 1 ml, amounts of a constant 
dilution of ^31%«.labelled serum Ty§ in tubes 7,5 % 1,2$ cm. Two rows 
of tubas were set up in duplicate* the first series of tubes (roi*jg A and 
B) contained serum diluted 1 in 4 throughout * the second series 
(rows G and D) contained serum Tra diluted 1 in 64 throughout. To each 
tube was added 2 drops of %  sodium aside solution. The tubas were 
kept at 4%, for 48 hours and the precipitates were deposited by 
cent?ifugation at 490, and washed* aa before* with cold saline solution. 
The supernatant solutions and some of the washing fluids were kept for 
radioactive counting and the precipitates were counted after each wash. 
In this way it was determined when most of the uncombinecl radioactivity 
had been removed by washing. A standard dilution of serum Tra was 
also made and counted at intervals? this control was prepared in order 
to make allowances for fluctuations which might occur In the well-type 
scintillation counter and in the mains electricity supply.
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SeElga,A..flM...B. Each précipitât®, thrice vasheû, was suspended In
2 ml. 0.1 M sodium carbonate solution and kept overnight at 490. It 
was then transferred to a clean tube and the original tube was rinsed 
out with a further 2 ml. of sodium carbonate solution which was added 
to the original 2 ml* volume containing the dissolved precipitate. The 
radioactive count-rate of the precipitate, now dissolved in 4 ml. 0*1 M 
sodium carbonate solution was then measured. The results are presented 
in Table 2 (p. 36 ) and are shown graphically in Fig. 6.
Considering that the precipitates were repeatedly washed before 
counting, the agreement in the two duplicate series is close. The 
results show that increasing the amount of antigen increased the amount 
of antibody precipitated* The super nates from series B, tubes 1 to S, 
ware tested for antibc^y excess by the Ouehterlony agar-gel diffusion 
technique ; excess antibody was shot-m to be present in all B tubes of 
series B, confirming that insufficient antigen had been present in any 
of the mixtures to annul the antibody in serum Tra. Thus the region of 
antigen excess was not reached.
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Concentration Dilution of Precipitate 
Counts per 100 sees*1 Tub© No* of antigen ^31% «.geru-m
1
added (% ) Tra added
Series A. Series B.
1* 100 1 in 4 19,350 18,250
2* 75 M  M  ft 15,300
t
3o 50 « 1? # 12,230 11,387
4» 33 M  ft tî 7,610 9,065
5. 20 ÎÎ If If 4,830 4,970
6* 14 «  If If 3,510 3,456
7. 10 t  «  If 2,480 2,300
a* 5 If If If 758 250
9. 0 If If If
Normal serum
0 0
10. 20 1 in 4
%
Not done
These results have been corrected by subtracting the counts per 
100 seconds due to background (300 counts per 100 seconds) and to 
the radioactive deposit in Tube 9 in which there was no thyroid 
extract (4*200 counts per 100 seconds in series A* 3,200 counts per 
100 seconds in series B). The radioactivity occurring in Tuba 9 is 
due to uncombined and probably denatured protein of serum Tra.
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Series G and D. The results for series G and D# in which serum Tra 
was used at a dilution of 1 in 64, are shown in Table 3 (p^  39 ) and 
graphica3.1y In Fig. 7. Again* there is fairly close agreement between 
these two duplicate series * The equivalence zone, where the curve 
flattens out, is shown* and at the highest antigen concentration there 
is a diminution in the amount of antibody precipitated. The supernotes 
1 to B of series D were tested for antibody excess in agar-gol diffusion 
tests. Marked antibody excess* demonstrated by the formation of well- 
defined bands of precipitate with thyrotoxic thyroid gland extract* was 
shown only in the 3 tubes containing the lowest antigen concentrations 
(Tubes 5“7). Faint precipitates were seen with the nerb two higher 
antigen concentrations (Tubes 3 and 4) and no lines were detected when 
the suparnatee containing 100# (undiluted) and 50% antigen dilution 
(Tubes 1 and 2) war© tested for antibody excess.
The results of the agar-gel diffusion tests on the su par nates of 
series B and D shoif, aa would be expected from the precipitin curves, 
that excess antibody was present in all tubes save those in row D 
containing the highest antigen concentrations. The antigen extract 
used in these tests was not very potent, and in series A and B the emiount 
of serum was too great to be annulled by the antigen present, 
therefore the zone of equivalence was not reached. In series G and D,
In which serum Tra was more dilute, the equivalence zone was reached and
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at the highest concentration of antigen* the fall in the amount of 
antibody precipitated suggests that excess antigen was present* and 
is consistent with the form of the classical precipitin curve,
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Tube No.
G oncent rat i on 
of antigen 
added (#)
Dilution of
-serum 
I m  added.
Prooi| 
Counts p©5
Series 0,
)itate
100 8008.
Series D.
1. 100 1 in 64 4U0 3576
2. 50 »ï « ft 4470 4125
3. 33 n M # 3411 3581
4 • 20 # 1» # 2298 2395
5o 14 I IÎ s! n 1669 1771
6. 10 fï SÎ M 779 1270
7. 5 II l> Ï 297 612
a. 0 II I M 0 0
9. 20
Normal serum 
1 in 64 - -
Baokgx*ound (300 counts per 100 secs) and the radioactive 
count in Tube 8 (11# counts per ICO aeos In aeries C* 1251 
counts per 100 gees in scries D) have been subtracted from 
these figures. The counts for tubes 9 were less than those 
for tubes 8 and the subtraction thua gives negative figures.
4#
Ira* In order to demonstrate more convincingly the inhibition of 
precipitation In the zone of antigen excess, the quantitative precipitin 
test with serum Tra labelled with was repeated using a more potent 
antigen* This antigen was prepared by extracting a thyrotoxic thyroid 
gland* concentrating a portion of this extract by freeae-drylng, and 
redissolving the freezo-dried residue in a volume of the remaining extract 
equal to the original volume of the freeze-dried portion* Before use 
as antigen* this extract was centrifuged at 34*000 g* for on© hour* A 
satisfactory precipitate was observed when this concentrated antigen was 
tested in an agar-gel diffusion test with serum Tra diluted 1 in 32*
Series K, and L. 4 ml. of the concentrated antigenic extract was mixed 
with 1 ml, of serum Tra used at a dilution of 1 in 27. The precipitates 
formed were treated in the same manner as before and the results are shown 
in Table 4 (p. 41 ) and given graphically in Fig, 8. As with the 
previous graphs for series A to D* no inhibition of precipitation is shown 
in the zone of antibody excess and in this respect the curves resemble the 
classical rabbit type curve described by Heidelberger and Kendall. In the 
zone of antigen excess* however, there is a very gradual decrease in the 
amount of precipitate produced*
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TABIE 4
An K Jj
Tube No,
G oneentration 
of antigen 
added (#)
Dilution of
-serum 
TSi added
Prreoip
Counts per
Series K.
Itate ^
100 secs.
Series L,
1, 100 1 in 27 3668 3193
'2, aa «Î U  IÎ 3705 —
3, 70 »  II IÎ 3484 4219
4# 60 fî If M 4431 3813
5. 50 « ÎI n 446)0 4050
6, 40 It ti ÎÎ 4971 4761
7. 30 « ÎI # 6073 5609
a# SO » # tt 5309 4622
9. 10 If tf ff 3563 3606
10. 0 ts n n 0 0
M5 and N5 i
1
50
Normal serum 
1 in 27
M I
*
These results have been corrected for background and 
non-spsciflG precipitation as In the previous experiments.
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The supernateg from series K were tested for antigen and antibody 
0X0088 in Ouehterlony agar-gel diffusion plates* The supernates of 
tubes K1 to K 8 were tested for antigen excess with serum Tr§ diluted 
1 in 32# Banda of précipitât© were obtained in agar-gel diffusion 
tests between serum T m  and the eupornatos of ICI to K5, thua indicating 
the presence of free antigen in these su per nates. Super nates K7 to KIO
were tested In the same manner for antibody excess with thyrotoxic 
thyroid extract as antigen. Free serum Tra appeared to be present only 
in the oupernate of KIO* in which the serum was mixed with saline 
solution instead of antigen. However, the dilution of serum in the 
original mixture* and therefore in the supernates * was much higher than 
the optimal dilution (1 in 32) for agar-gel precipitin tests ? moreover* 
the precipitin in serum Tra was not titrated after labelling with ^31% 
and may have been weakened by this procedure*
Conclusion, The qu.antitativa precipitin curve* produced between serum 
Tra and dilutions of a thyroid extract antigen, is essentially of the 
classical (*rabbit’) type described by Heidelberger and Kendall, in 
which there is no Inhibition of precipitation In antiboriy excess. The 
unuBuall^r high protein content of the mixtures may have been responsible 
for the atypical appearance of the precipitin curve in the region of 
antigen excess.
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FractiamatiAm of
In an attempt to elueidate the nature of the antigen reacting with 
serum Tra, fractionation of various tissues was performed to isolate 
the cellular conatltuente, i.e. nuclei, mitochondria, microsomes and 
soluble protein. Two methods of fractionating the tissues were employed. 
The first was the method of differential centrifugation in 0.25 M sucrose, 
described by Hogeboom and Schneider (1955)# The second method made use 
of a 1# solution of citric acid in order to provide nuclei free from 
contamination with cytoplasmic particles or soluble protein (Mirsî^ y and 
Follister, 1946, Bounce, 1955)#
This technique has been used mainly to fractionate liver tissue.
Three specimens of liver and one of spleen were obtained shortly after 
death, A temperature of 0-4%# was maintained throughout the procedure.
(Table 5, p,44).
à 10# homogemt© of the tissue was made in 0,25M sucrose in a 
mechanical "Teflon" piston-type homogenlser. This homogenate was 
centrifuged at 700 g, for 15 minutes* The deposit obtained after 
centrifugation, examined microscopically, was observed to toe composed 
principally of nuclei and a few Intact celle. The suparnate* almost free 
of nuclei, was centrifuged at 12,000 g, for 20 minutes. The deposit at 
this stage, when examined microscopically was found to consist principally
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Fractionation In aucros©
1 vol. liver in 9 vol 0.25M suci’os©
Homogenised
Centrifuged at 70Dg.
Bupernate Deposit
(a nuclear preparation) ^
Centrifuged at 12,000g.
Supernat© Deposit
mitochondrial preparation) — ^
Centrifuged at
24,000g.
'4/
Supernate 'Deposit
(soluble protein (= "microsomal" preparation) —  
•t* some ïïiierosomes)
Tost with 
serum Tra
weakly
positive
negative
negative
negative
** 4.-5
of mitochondria# Further centrifugation at 34$000 g* for 1 hour gave 
a deposit composed of very small particles (*microaome$*) and a few 
mitochondria# The deposits obtained at each stage of fractionation 
were washed once by suspending in 0#9l saline solution^ eedimenting 
again by oentrlfugatlon, and resuspending in an equal volume of saline 
solution#
The fractions were tested Immediately without any further treatment 
and again after freezing and thawing 3 times In order to disrupt the 
subcellular particles. When tested with 1 in 32 earuau in agar-*g©l 
diffusion tests, the deposits consisting of nuclei were either negative 
or reacted to give a faint précipitât© i the deposits containing inito—  
ohondrla and mlorosomes were Invariably negative# The supernatant fluid 
(soluble protein) of this fractionation was negative with serum Tra. Since 
this supermte was produced by mining one volume of tissue with 9 volumes 
of 0,25M sucrose, it was not unexpected that this fraction failed to react 
in an Ouchterlony test W.th serum Tra (see p# 21 ) # the suparnata of a 
30% crude tlaaue extract In 0*23M sucrose, centrifuged at 34,000 for one 
hour was always positive* It Is reasonable therefore to assume that the 
supernate of the 1(% tissue extract was too dilute to react with serum Tra.
Microscopic examination of the nuclear preparation obtained in 
sucrose showed it to contain some whole cells and mitochondria#
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Accord5,Bgly, the cltrle acid method of fractionation was employed to 
obtain nuclei free from oontaraimtion with cytoplasmic constituents.
Four specimens of human spleen were extracted by the citric acid, 
method, the temperature being maintained at 0-4%# throughout this 
procedure. (Table 6, p. 47) = One volume of sieved splenic tissue and 
nine volumes of %  citric acid were homogenised and centrifuged at 
1000 gé for 15 minutes to deposit the nuclei* When the eupernate from 
this extraction was tested, without further treatment, in an Ouchterlony 
agar-go 1 diffusion plate with serum used at dilutions of 1 in 8 and 
1 In 32, no precipitate was obtained# The eupernate of a 50% extract 
of the same spleen in saline, however, gave a positive test with serum 
Tra* The nuclear deposit of the citric acid bomogemte was washed once 
with an equal volume of buffered saline at pH?#2 and re sus ponded in 
buffered saline* This neutralised deposit gave precipitates with both 
dilutions of serum Tra. The supernote obtained after citric acid 
homogenisation (pH 4,5) was adjusted to pH 7*2 with dilute sodium 
hydroxide solution and retested with serum Tra in an agar-gel diffusion 
plate. This neutralised supernate again failed to give a precipitate 
with serum Tra.
Sieved splenic tissue was homogenised in an equal volume of %  
citric acid and the homogenate (pH 4,5) was divSJed into two portions# 
(a) The first portion of the homogenate was centrifuged at lOOOg. for
47
TABLE 6
1 vol* eploen in 9 vols* If citric aeid
Supernat© 
(- pH 4,5)
Neutralised with 
HaOH
\ ________
Horaogonised
Goiitrifuged at lOODg#
, T
Deposit 
(=2 nuclear préparation)
Washed in buffered 
sailne (% pi 7,2) -
Test %\Tith 
serum Tra,
positive
negative
negative
1 vol. Spleen in 1 vol. citric acid
Homogenised
4
Homogenate (=pH 4*5)
(a) Centrifuged at lOOOg, (b) Neutralised with HaOH
,1
Deposit Supernate
Neutralised with NaOH
V _____________
Teat with 
serum T%%
Centrifuged at 1000 g.
Deposit. ' Bupernate — ^  positive
negative 
^ negative
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115 minutes to deposit the nuclei and the supernata tested both before 
and after treatment with dilute sodium hydroxide solution to adjust the 
pH to 7,2, Both the untreated and the neutralized supernate failed to 
give a precipitate with serum Tra, (b) The second portion of homogenate 
(uncentr5.fugad ) was adjusted to pH 7,2 with dilute sodium hydroxide 
solution ard then centrifuged at 1000 g, for 15 minutes, The supernate 
of this neutralised homogenate^ tested with soium Tra, reacted to give a 
precipitate in an agar-gel diffusion test.
Acidification of a 50-1 saline extract of spleen.
The effect of acidification to #14,5 of a 5 %  extract of spleen in 
saline solution was examined. The extract was centrifuged at 17^000 g, 
for 15 minutes at 4%* and the supernate ad justed to pH 4,5 by the 
addition of dilute hydrochloric aeid, IJhen this acidified extract was 
centrifuged at ISyOOO g, for 15 minutes^ a large deposit was obtained.
The eupernato was removed^ neutralised^ and tested in an agar-gel diffusion 
test 5 no precipitate was obtained with 1 in 32 serum Tra. The deposit 
from this acidified extract was suspended in saline solution and ad justed 
to pH 7,2, This neutralised suspension was positive with serum Tra in 
an agar-gel diffusion test. The supernate^ obtained after centrifugation 
of the neutralised suspension, was also tested and shown to ba positive,
tlotlQlHSlon. ïhe tissus extract antigen reacting i-jith serum appears
to to© praeipitateci at pH4*5 and recfisaolves when the pH ie adjusted to 
7.2.
Differential centrifugation wag performed on a homogenate of rabbit 
liver in 0,25 M sucrose^ a temperature of , being maintained
throughout the procédure. The taohnique was as already described for 
human liver and spleen.
Til© deposits obtained after each centrifugation were washed 
separately in 0,25 M micros© and examined microscopically. The first 
deposit nuclear’) was shown to consist principally of nuclei but 
contained also some unbroken cells $ and mltoohonSrla ; the second 
consisted mainly of mitochondria and the third contained many vary small 
participa ("microsomes") with few mitochondria.
Serum Tra* diluted 1 in 15, was mixed with equal volumes of the 3 
deposits. In the final auparnate, aorum Tr§ was added to a final 
dilution of 1 In l6. These mixtures were kept at 4%. overnight and 
centrifuged on the following day at 24,000g, Doubling dilutions of the 
supernate8 of these mixtures were tested againat antigens consisting of 
a 50| extract of whole rabbit liver in 0,25 M, sucrose and a 5 0  saline 
extract of a thyrotoxic thyroid gland extract, k control consisting of 
doubling dilutions of an untreated 1 In 16 dilution of serum Tra was also 
tested at the same time. Only the final eupernate (soluble protein)
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caused a mairked reduction in the titra of serum Tra# the reduction In 
titre being the same for both antigens.
«jsONsærcSofiRraBKixsrs^uflan^Laijon. Fractionation in 0*25# sucrose of the tissues obtained 
j^ qatynortem was not successful In giving complete separation of the 
cellular constituents, but the results suggested that the antigen for 
serum Tra was absent from mitochondria and microeomes. The antigen was 
altaays present in the suparnate of 50 extracts in 0*25# sucrose, and 
occasional weak reactions were observed with nuclear preparations. The 
results vQ'r citric acid treatment, which it was hoped would demonstrate 
the presence of absence of antigen in the cell nuclei, suggested that 
the antigen was present in the nuclei? however, when the homogenate 
was neutralised before centrifugation, the antigen appeared in the 
aupernat©. The antigen thus appears to be insoluble in 1$ citric acid, 
and its presence in some citric acid preparations of ’nuclei’ does not 
indicate its sit© within the cell. It may, indeed, be a nuclear 
constituent extraotable by saline or sucrose, but not by citric acid.
On the other hand, it is ecpaUJly possible that the antigen is a 
cytoplasmic constituent and that it Is precipitated and on centrifugation 
is deposited with the nuclei, in citric acid homogemtes.
These inconclusive results are merely <an illustration of the 
uncertainty of the origin of any cellular constituent detected in the 
supernatant fluid of tissue homogenates.
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In order to determine whether the antlbaly of serum Tra could be 
detected by a technique other than the precipitin reaction, complement 
fixation tests were performed, using extracts of human tissues as 
antigens. The technique used ie described on p* 149.
Serum Tra was tested in doubling dilutions with extracts of fresh 
.pmt-mortem tissues of thyroid, adrenal, liver, kidney, and salivary 
gland and with surgically-removed thyrotoxic thyroid gland extracts. 
Complement fixation titres of serum Tra were high with all tissue 
extracts tested, generally being of the order of 1 in 512 or higher* 
’’Chessboard*’ titrations in which each of a series of doubling dilutions 
of serum Tra was tested with a series of doubling dilutions of tissue 
extracts, were performed, using thyrotoxic thyroid and pa.rotid gland 
extracts, by the method of Donnelley (1951) which employs only 2 drop 
volumes of reagents. A stepwise decrease in titre occurred as the 
concentration of tissue extract diminished # Table 7 (p, 53 ) 
illustrates the results obtained with an antigen extract of thyrotoxic 
thyroid gland *
A precipitating factor, subsequently shown to be an antibody, was 
detected in the serum of a patient Tra with Sjogren’s syndrome# This 
antibody (anti-8jT) reacted to form a precipitate with extracts of
“■ 52 ““
various human tissues from all individuals tested and with extracts of 
lymphatic leukaemia leuoocytes.
Attempts to determine the intracellular site of antigen Sjf were 
unsixcoeaaful by the methods of tissue fractionation available* Antigen 
3JT was unaffected by treatment with deoxyribonuclease and ribonuolease 
and was destroyed l^y treatment with trypsin and chymot^ypsin*
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’’Ghessboard” titration between seruEi-Tra and thyrotoxic
thyroid extract
Dilutions 
of thyroid
extract
Dilutions of serum Tra
8 16 32 D4 256 512 1024
1 4'i" ++ 4*^, 4* 4* 4*4- ** 4*1'
2 4*4* 4*4* 'T'î* 4*4* 44 **
4 'i*4- 44. •I-4* 4-4- ■j-4* 4. 4. -
a 4'4' 4"!* 4».|* 4. - - «. -
16 * - ** «« “ - <w
32 4* "W iM w ww ## WB* w#
no lysis; % partial lysis; - ^ complete lysis
Further
extracts In  tbe . aemm gf s syndrome
In view of the results obtained with eemn serum was obtained
from a further //> patients with Sjdgren’s syndrome. Diagnosis was made 
by the clinicians supplying the serum and was based on the patient’s 
case history, clinical observations, and supported by positive Schirmer 
and rose-bengal testa.
In a study of Mikulicz’s disease, Morgan and Oastlaman (1953) 
showed that the pathological changea in the salivary glands wore closely 
similar to those found in the lacrimal glands in Sjogren’s syndrome and 
suggested that since the two conditions bore such close pathological and 
clinical resemblances, they might ba anatomical variants of the same 
disease, Morgan (1954) réinvesti gated 18 patients with MUmliez’s 
disease and concluded that the pathological lesions occurring in the 
salivary glands were identical with those found in SjcSgren’s syndrome ; 
clinical features which occur in Sjogren’s syndrome, such as rheumatoid 
arthritis, keratoconjunctivitis aicca, and xerostomia, were also observed 
in many of the patients with Mikulicz’ s disease. From this and otho'r 
studios (e.g. Shearn, 1^ 1), it la apparent that the two conditions 
cannot readily be separated and in the present study histologically 
confirmed cases of Mikulicz’s disease have been included under the heading 
of Sjëgren’s syndrome.
- 53 -
For convenience, sera obtained from patients with either 
Mikulicz’s disease or Sjogren’s syndrome, will be referred to as 
’’Sjogren sera/’
A total of 48 Sjogren aera, including the 2 sera already tested 
(p* l6 ), were examined for precipitating antibodies to human tissue 
extracts by the agar-gel diffusion technique, 15 eom, Initially 
tested both undiluted and diluted 1 in 8, were found to contain
precipitating factors reacting with thyrotoxic thyroid extract. The
precipitates produced were very similar in appearance to that given by 
semra Tra. although some were very slightly concave towards the serum 
well. Certain sera gave two bands of precipitate, and one {serum Bcr) 
gave three well-separated bands of precipitate when tested undiluted 
(Fig, 9) t at a dilution of 1 in 8, two bands of precipitate persisted 
with some of these sera; on testing in serial dilutions, on© band of 
precipitate generally disappeared before the other.
All positive sera were titrated, using twofold dilutions of serum, 
with an extract of thyrotoxic thyroid. Precipitating titres ranged 
from 1 In 1 to X in 512; 5 sera had precipitating titres greater than
1 in 8 (see Table 9, p, 68 ), In 5 sera the precipitating factors were 
strong enough to allow of their comparison with each other and with that 
in serum Tra by means of direct tests for identity and antigen annulment 
tests.
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In order to determine whether this preolpltin reaction was spécifié 
for Sjogren sera, 200 spocimenB of serum obtained from surgical, medical 
and gynaecological cases were tested for precipitating factors to tissue 
extracts* Two of these sera were found to give precipitates ? one of 
these reacted only when undiluted and was from a patient with aplastic 
anaemia who bad no history or symptoms of SjBgren’s syndrome or of any 
other connective tissue disease and who bad had repeated blood transfusions* 
the other was from a patient with a parotid swelling which was later 
diagnosed by biopsy as Mikulicz’s disease? this serum reacted at a 
dilution of 1 in S but insufficient was available for titration or other 
immunological investigations and the patient did not return to hospital.
Serum was also obtained from 33 patients with other salivary and 
eye conditiona, including parotitis, submandilmlar duct calculus. Iritis, 
orbital granuloma, etc. Only one seium reacted weakly when undiluted 
and this was from a patient with sialaetasis, believed to be due to 
bacterial infection| no histology was available from this patient, 
therefore this diagnosis is uncertain.
fiaiEa£isj
For the reasons given on p. 23 an extract of thyrotoxic thyroid 
gland was used for these tests* Taste with extracts of other human
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tissues are described on pp. 19-20, 62-64, Some thyrotoxie thyroid 
extracts were found to be more suitable than others for comparison of 
serum precipitating factors*
Precipitating sera from patients with SjSgren’s syndrome were tested for 
reactions of identity, partial identity and non-identity in agar-gel 
diffusion tests. The limitations of this method have already been 
referred to on p. 22. The appearances of such tests are illustrated 
in Fig. 10 which shows reactions of identity and of non-identity.
When seruia Tra (containing antibody designated anti-SjT) was compared 
with other precipitating sera, it was found that serum from a patient 
Dorn (precipitating titre 1 in 64) gave a precipitate which crossed that 
formed by serum Tra, indicating non-identity of the precipitating factors 
in these 2 sera. The precipitating factor in serum Don was therefore 
designated anti-8 jD (evidence for Its antibody nature is given below). 
Another serum from a patient Ral gave 2 well-separated bands of precipitate, 
one of which gave a reaction of identity with sermi Tra. indicated by 
fusion of the precipitatee; the second band of precipitate formed by 
serum Hal crossed that formed by serum Tra and fused completely with the1—KStmacrei ft* «KawagwA» ft t*
precipitate formed by serum It was therefore concluded that serum
Ral contained both anti«8jT and anti-SjD. Another serum was found by
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this method to contain both anti-SjT and antl-SjD; this serum (Mu) 
usually gave only one band of precipitate although 2 bands were seen In 
acme teats. It thus appears that this latter serum P %  contains both 
factors and that the precipitates are usually superimposed on one 
another to give a single line. The occasional separation of the 
precipitate formed by serum Flu into 2 lines is probably dependent upon 
the proportions of the factors SJT and S;]D In the tissue extract used in 
the test. A third antibody, not detected in the serum from any other 
patient with Sjdgrsn’s syndrome, was found to occur in serum Scr, which 
also contained both antl-SjT and anti'8 jD. This serum gave 3 bands of 
precipitate when tested undiluted. The precipitating factors in the 
other 10 sera were too weak for identification,
of the method of comparing the precipitating factors in sera by annulment 
of antigen in human tissue extracts is given on p. 146, The results 
obtained by this technique confirmed the conclusion drawn from the 
direct identity tests that there are 2 distinct types of precipitating 
factors among the positive SjcJgren sera. The results of these antigen 
annulment tests are summarised in Table 8, (p* 59).
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ijia
H
sera
î©eted
with
serum
Plu
Thyroid extract treated with serum of
I m  S m  ImiBsB 1 £te- SSE Normal
serum
Identity of 
precipitating 
a
4 antl-3 JT
anti-Li,
(anti-SjT 
(anti«8jï>
(antlm^jT
(anti-8jD
(antl-SjT
(anti-SjD 
(anti- ?
Normal 
serum
>»M iam ilBawa<lBM M iB5m iM W W >»»W M IW ig3l>W »»ll|M »lp<iaK«lW »awy,(M tjM SKSf,aiW illW ^ ^
As reported on p*$8 this scrum contains a third, unidentified 
precipitating factor.
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PxrefilBltatlng .t,bm oglotelln in  S.iagren aera.
Since thyroid extract has generally been need for testing these
sera in agar-gel diffusion plates, it might be expected that any serum
containing precipitating antibody to thyroglobuXin wtould give a positive
result. However, the thyroid extract used as antigen in the detection
of serum precipitating factor to tissue extracts is much more concentrated
than the optimum dilution of thyroid extx^ aet used in the detection of
antlthyroglobuXln (Anderson, Buchanan, Gouclie and Gray, I962)#
Antithyroglobulln precipitates appearing in these teats are therefore
very close to the serum well and are observed to migrate even nearer to
the serum well when the plates are examined at daily intervals,
Three Sjogren sera, tested using thyrotoxic thyroid extract as
antigen, gave precipitates which appeared likely to be due to
antitbyroglobulln. These sera were therefore tested with a solution of
’purified’ tbyroglobulln ^ (Berrien, Michel and Rocha, 194B) at a
concentration of fi mg./ml. as antigen. ill 3 formed a precipitate with
this preparation. The presence of precipitating factors other than
antithyroglobulin was confirmed in 2 of these 3 sera using extracts of
human tissues other than thyroid* These latter precipitating factors
gave weak reactions and could not be identified as either anti-8jT or
anti~8jD, Mono of the other 45 SJëgren sera reacted to form a
Dr. I.M# Koitt of the Middlesex Hospital, London, kindly 
provided a supply of purified human thyroglobulin*
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precipitate with purified thyroglobulin* The highly sensitive 
tanned red cell agglutination test for antibody to thyroglolmlin 
was also performed on 26 Sjëgren sera, and the results are reported 
and discussed on pp. 117-12$,
62
The precipitate formed by serum Don in agar-gel diffusion tests 
is generally slightly concave towards the serum well (Fig. 11) unlike 
that formed toy serum Tra whioli ie straight (Fig# 1), The precipitate 
generally appeared in 24 to 48 hours.
Immunoelectrophores!s of serum Don was carried out as described on
p* 14*7• This showed that the precipitating factor anti-SjD had the 
electrophoretic mobility and pattern of gamma-globulin*
Fractions of seiaini Don prepared by Dr. Gharlwood ware tested in 
agar-gel diffusion plates. The precipitating factor in serum Don was 
present only In the 3 fractions which were found toy Dr* Oharlwood to toe 
those containing 7S gamina-glotoulin.
From the results obtained toy immunoeleotrophoresis and ultra­
centrifugation it is concluded that the precipitating factor in serum 
Don is an antibody.
iBClclenog. of antigen S.iP in toman tlaaw extraotg.
The incidence of the precipitating antigenic factor in human
tissue extracts reacting with serum in agar-gel diffusion tests 
appeared at first to correspond rather closely to that of serum 
Antigen SjD was demonstrated in extracts of thyroid, adrenal, liver, 
kidney, spleen, testis, and salivary glands, and in extracts of 
3_ympbatic leulcaemic leucocytes obtained from peripheral blood. In 
order to determine whether it was present in the tissues of all 
individuals, a series of 90 thyroid extracts, including both surgically- 
removed and post-mortem material which bac3 been stored at -20%# for 
various periods up to 2 years, were tested with serum Don used at its 
optimal dilution of 1 in l6. Approximately half of these extracts 
reacted to form precipitates with serum J3on* A series of extracts of 
thyroid and either spleen or aubmanrSibular gland obtained post-mortem 
from 40 Individuals were made and tested with serum Don immediately after 
extraction? 55 of the 80 extracts reacted with serum Don. Reactions 
were observed with tooth extracts from 20 individuals, and with either 
one, but not both, extracts from 15 individuals. Thus the antigen was 
detectable in the tissues of 35 of the 40 inflivlduals tested. Since the 
positive testa with aeram Don indicated that the antigen was present in 
veiy small amounts in some of the tissue extracts, the extracts from the 
5 individuals giving negative results were concentrated by freeze-drying 
the extracts and redissolving the residue in water to ha1.f the original 
volume# On testing these concentrated extracts, positive results were 
obtained with the tissues of 3 of the 5 individuals.
Of the 2 individuals whose tlaeua extracts did not react with 
aorujA Don» one was a woman who had died of progressive systemic 
sclerosis * Her tissue extracts were observed to react to form a 
precipitate with the tissue extracts of other lndivj.duals. As sbavn 
later, patients with progressive systemic sclerosis frequently have 
precipitating antibodies, including anti-SjD, in their semm, 
Unfortunately, serum wqs not available from this ps,tient, but the 
failure of bar tissue extracts to react with serum Don* and their 
reaction with other tissue extracts, strongly suggests that this patient 
had anti'^jD in her serum and that this antibody, present in the blood 
within the tissues, had completely annulled the 8jD factor in the tissue 
homogenates. The other individual whose tissue failed to react with 
serum Dgn died after gastrectomy for carcinoma of the stomach. Before 
operation, she had a reaction after being transfused for a second time 
with 2 to 3 pints <£ blood. This patient had a history of dry eyes 
and mouth % she had what had been regarded as a nodular goitre although 
7 years previously she had been shown to have a low basal metabolic rate 
( -40 ). It la thus possible that this patient was a case of 
Sjogren’s syndrome, associated as it commonly ie, with chronic 
thyroiditis, Poat-mortiem examination of the thyroid was not performed 
in this ease.
65
Liver, kidney and spleen extracts were prepared from organs 
obtained from rabbits, guinea pigs, rats, and mice, and were tested 
Immediately after extraction# Serum Don was found to be positive only 
with extracts of guinea pig organs*
. P R c q n t a % r ^ j , , i 3g .aptjgeK^jP
Serum Dgg (containing antl-SjD) was heated for 2 hours at 55%*
Heated and unheated serum at dilutions of 1 in 8 and 1 in 64 was then 
tested for anti-SjD and equally good reactions were obtained with the 
heated as with the unheated serum dilutions*
Specimens of a thyrotoxic thyroid extract were heated at temperatures 
of 3?%*, 45%*, 55%.$ and 65%* for 30 minutes* The results of 
precipitation tests, using semii Pop diluted 1 in 16, shomd that 
antigen SjD was not destroyed after heating at temperatures up to 55%* 
After heating at 65%,, however, antigen SJB was not detected in the 
extract *
Experiments involving treatment of tissue extracts with crystalline 
trypsin, ehymotzypain, deoxyrlbonuolease and ribonuclaase have already 
been described on pp. 27 » 28 where the treated extracts were tested 
x^ ith serum Tra* Enzyme -treated extracts were also tested in
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Oueht©i'’3,ony tests with serwn Don. Tissue extracts treated with 
trypsin and chymotrypain gave a slightly weaker reaction with serum 
Dgn than with the untreated control extract which had been incubated 
at 37%. for the same length of time as the enzyme-treated extracts.
Deoxyribomclease and ribonucleasa ware without effect on antigen 8jD.
Antigen SjB resembles antigen S;jT in that it occurs in a wide 
variety of human tissues from all individuals tested and in lymphatic 
leuicaemic leucocytes ; it is unaffected by treatment with deoxyribo- 
nuclease and ribonucleas©# Unlike antigen S;]T, antigen SjD deteriorates 
when stored at -20%* (p. 63 ), On the other hand, antigen SjD resists 
heating to a higher temperature than antigen SjT and is moi'e resistant 
to treatment with the enzymes trypsin and chymotrypain.
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Immunoelectrophorasis was also performed on serum Hal and serum 
Zte the precipitating factor in both these sera shown to have the 
electrophoretic mobility and pattern of gamma-globulln#
*0aü£î wj.
8 *1 Offre n* g
Complément fixation testa were performed on SjBgren sera by the 
method described on p, 149 using extracts of normal human thyroid and 
kidney as antigens. Sera containing antl-SjT usually reacted to fix 
complement with both antigens, Sera containing anti-SjD varied in their 
ability to fix complement. Complement-f 1x1 ng sera usual3*y reacted to 
the same titre with both kidney and thyroid extracts.
Seram
Oomplemen'
with e%i
w/jaB({EW,rj j h'Aiwiuwmfwfkf
thyroid
^-fixing titra 
bracts of
Kidney
Precipitating
titre
Identity of
precipitating
antibody
tra 512 10% 256 antl-^ î jî
Don A 64 anti-SJD
Ral 1024 10%, 64 (anti-SJT
(antl-^jD
Pin 256 256 64 (antl-SJÏ
(antl-8JD
Kl0 4' 4^ 4 antl^jD*
Har 4 4 1 not
identified
Wal 4 4 4 ÎÎ
War 4 16 4 SÎ
Bor 64 256 512 (antl-SJT
(anti«SJI) 
(anti- ?
* Identified only by direct tests for Identity.
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Heaton (1959) has drawn attention to the clinical and pathological 
similarities oocmTing between SjSgran^s syndrome and systemic lupus 
erythematosus^ and between Sjogren*s syndrome and Hashimoto*s 
thyroiditis* As result of these observations, he suggested that an 
auto-imnmne phenomenon^ for which strong evidence exists in systemic 
lupus erythematosus and Hashiraoto’s thyroiditis^ might also be concerned 
in Sjogren’s syndrome. Moreover, Jones (1958) had described the 
occurrence of precipitating factors reacting with lacrimal and salivary 
tissue in the serum of patients with Sjogren’s syndrome* The present 
investigation is an attempt to determine whether precipitating auto- 
antibodies are detectable in Sjogren sera, and if so, whether they react 
specifically with salivary or lacrimal tissue constituents
Of 48 sera from patients with Sjogren’s syndrome, 15 were found to 
contain precipitating factors which reacted not only with human salivary 
tissue extracts, but with a wide range of human and certain animal tissue 
extractsc These reactions were demonstrated in Ouchterlony agar-gel 
diffusion teste in which the wells containing the serum and tissue 
extracts were larger, and more closely spaced than is customary in such 
tests* The precipitating titres of tissue extracts were low and 
dilution of the extract resulted in diminution in the amount of
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precipitate. In contract, the oormn from some patients was of high 
titre5 2 sera reacting at dilutions up to 1 in 256, These findings 
disagreed uith those described \rj Jones in that be found that the serum 
reacted only uVion undiluted and bis e%t,racts were appreciably more 
dilute than those used in this investigation.
Comparison of the precipitating factors was possible with sera of 
high titre. These factors were shcïvm to W  of two distinct types^ 
termed anti-SjT and antl-S;]D| one serum (Bgt) contained a third factor, 
in addition to the other two.
The antibody nature of anti-8jT and anti-SJD was established by 
showing that they were 78 gamma-globulins and exhibited distinct 
specificity * tissue extracts annulled by treatment with one antibody 
remained capable of reacting with the other, Furthei’more, by labelling 
serum T^a (ant 1-41 jT ) with radioactive iodine a quantitative
precipitin curve, of classical form, was demonstrated by adding increasing 
concentrations of a tissue extract to constant amounts of serum Tra,
The occurrence of the corresponding antigen in the tissues of all 
individuals tested, suggests that anti-8jT and anti-SjD are autoantibodies 
Their auto-lmmune nature was confirmed (see p, 107 ) when tissue extract 
from an Individual with rheumatoid arthritis, whose senmi contained both 
antibodies, was found to react with her own serum, with serum Trg 
(anti-8jT) and with serum Don, (anti-S;)D),
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Antl-SJT and antl«8 ;jD were shot-in to react with extracts of all 
highly cellular tissues tested. The intracellular nature of the 
corresponding antigens was established their detection in extracts 
of lymphatic leukaemic leucocytes. Attempts to establish the intra­
cellular site of antigen BJT by tissue fractionation demonstrated its 
presence in *cell sap’ (soluble protein) and inconstantly in nuclear 
extracts* these results do not reveal whether the antigen is of nuclear 
or cytoplasmic origin, for in any cell fractionation there is the 
possibility that material will diffuse out of one of the particulate 
cellular constituents and appear In the ’cell sap’ while preparations of 
suboellulai' particles may contain precipitated cytoplasmic material, 
Qonsoquently this methtxâ is of limited valu®,
Antigen SjT was shown to be more susceptible to heat and the action 
of proteolytic enaymes than antigen 8jD and may thus be of protein
nature. The precipitate between serum Don and antigen SjD was slightly
concave towards the serum well, suggesting an antigen of lower molecular 
weight than 7S gamma-globulin (Korngold and Van leauwen, 1957), The 
resistance of antigen SjD to the effects of heat and onayme action
suggests that it is probably not a protein.
Jones considered that the precipitating factor in Sjëgren sera was 
likely to be Bp^ fcifie for lacrimal and salivary tissue extracts, but 
nevertheless he reported that it reacted also with certain human kidney
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extracts, Antl«8jT and antl-8jD are certainly not organ-specific.
Their reactivity with a wide range of human and certain animal tissue 
extracts is in sharp contrast to the behaviour of the antibodies present 
in the serum in the majority of cases of Hashiraoto’a thyroiditis which 
react specifically with thyroid tissue comtituents*
I am not aware of any other reports describing the occurrence of 
precipitating autoantibodies in SJ5g:f©n*s syndrome although antibodies 
have been demonstrated by the technique of complement fixation and the 
fluorescent antibody technique for anti-nuclear factors.
Complement fixation reactions between Sjogren sera and human and 
animal liver and kidney antigens were reported by Delohor, Holman and 
Kiinkel (3.960), Bloch, VIohl, Ship, Oglesby and Bunlm (i960) reported 
complement-fixation occurring between serum from patients with Sjogren’s 
syndrome and extracts of, human submandibular gland, liver, kidney, and 
striated muscle. Such non-organ-speoific complement fixation reactions 
were also described by Gajdusek (1958) as the %uto-imiaune*’ complement 
fixation (A.I.O.F.) reaction, which he reported as occurring in high 
titre in the sera of some patients with systemic lupus erythematosus, 
primary biliary cirrhosis and maoroglobulinaemla, Heaton (I962) has 
reported a higher incidence of A,X,0,F, reactions, using human thyroid 
and liver or kidney antigens, in a series of patients with Sjogren’s 
syndrome than in a series of patients with systemic lupus erythematosus.
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In the present investigation, comp3.0raont-fixatlon testa were performed 
using extracts of human thyroid ami kidney tissues as antigens. A 
few sera contained factors which reacted to fix complement with both 
tissues, the titre being approximately the same for each tissue extract, 
Comparison of the complement-fixing titres with the precipitating titres 
showed that semm containing anti»-3jT generally reacted to fix complement 
and the titres of precipitating and complement-fixing antibodies were of 
the same order in each semn. Sera which contained anti-SJD varied in 
their ability to fix complement, however, and most, but not all, non- 
precipitating sera failed to fix complement,
The fluorescent toehnli^© for the detection of intraeelliilar antigens 
was perfoi'med by Dr, J,S, Beck on 44 of the sera from patients with 
Sjogren’s syndrome* The tests wore performed using unfixed sections 
of rat and frog livers. The sections were treated first of all with 
the patient’s senam, washed to remove unattached gamma-globulin, treated 
with f luores CO in-conjugated rabbit anti-human gamma-globul.ln and then 
washed again to remove unattached serum-conjugate. The presence in the 
test serum of antibody to the tissue constituents, was thus made visible 
in ultraviolet light by the attachment of fluorescent serum-eonjugate to 
antibody gamma-globulin. Four distinct patterns of fluorescence were 
observed in those sections* those were diffuse cytoplasmic, homoganeous 
nuclear, spockled nuclear and nucleolar fluorescent staining. {B©ck,19ol)
1*5ii\,
Positive results occurred both in sera which contained precipitating 
antibodies and In non-precipitating sera. The fluorescent antibody 
tltros wore, in general, higher in sera which contained precipitating 
antibodies. It was shown that sera containing anti-8;]T invariably gave 
speckled nuclear and diffus© cytoplasmic staining but the titres of 
neither bore any relationship to the titres of precipitating antibody*
Sera containing anti-SjD produced diffuse cytoplasmic and either 
homogeneous or speckled nuclear fluorescence* The nucleolar pattern of 
fluorescence was encountered in only 2 sera, one of which contained no 
detectable precipitating antibody and the other was serum Scr., which 
contained both anti-SJT and aiiti-SJD and also a third precipitating 
factor. Since antigen SjT and antigen BjD have not been demonstrated 
in rat tissues in precipitin testa, it was important to ascertain whether 
these patterns of nuclear, nucleolar and cytoplasmic fluorescence were 
also obtained with human tissue sections* Using a few, selected Sjogren 
sera and tissue sections of human thyroid and liver, Dr. Beck demonstrated 
the same patterns of fluorescence that he had found previously with tissue 
sections of rat and frog livers. The pattern of fluorescent staining
obtained with Sjogren sera could not be correlated with the presence of 
either anti-8 JT or anti-SJD* Both preolpitatlrig antigens, hoimver, have 
been shown Intracellularly and it ie difficult to understand why they 
cannot be demonstrated by this very sensitive fluorescent antibody
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technique. It may be that the antigens concerned in the precipitin 
reaction are very soluble and diffuse out of the tissue sections during 
their preparation and processing.
The possible significance of the occurrence of precipitating 
antibodies in Sjogren’s syndrome is discussed further in the general 
discussion on pp. 126-14.0.
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In the previous section, precipitating factors, regarded as auto- 
antibodies to tissue constituents, were demonstrated in the serum of 
patients with Sjogren’s syndrome* In view of the association of 
Sjogren’s syndrome with the connective tissue diseases (Oarclell and 
Gurllngg 1954, Beaton, 1959, Bunlm, 1961, Bhearn, I960, 3.961), it was 
decided to tost serum from patients with connective tissue diseases for 
antibodies by the same technique. Serum was obtained from patients with 
systemic lupus erythematosus, discoid lupus erythematosus, progressive 
systemic sclerosis, dermatoaiyositis, and rheumatoid arthritis* These 
sera were tested in agar-gel diffusion plates, with the following results.
S :!^ ^ # jLJ3aa4S--gJ3düiMMjm g
Of 29 cases of systemic lupus erythematosus, 20 were found to have 
in their serum precipitating factors to human tissue extracts. In 15 
of these positive cases, tests were performed on 2 or more specimens of 
riorum obtained at intervals ranging from one month to 2 years ? 12 patiente
had serum specimens which were positive on all occasions and 3 patients 
gave specimens which were positive only once* The serum factors 
frequently became weaker or disappeared during steroid therapy* this
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change wae not!ceci within on© month of the commencement of therapy.
The stronger serum precipitating factors detected In this series of teats 
were compared with each other and with anti-8jT and anti-SîjD hy direct 
teats of identity in Ouchterlony plates and by antigen annulment teste 
as described on p*146. Anti-SjT and antl-SJD wore unequivocally 
identified and in addition 3 other typos of serum precipitating factor 
were demonstrated * The Identification of these 3 serum precipitating 
factors is described on the following pages.
I The ïtor in serum Dun
This gorum was obtained from a patient (Dun) with untreated systemic
lupus erythematosus, Agar-gal diffusion testa performed between this 
serum and human tissue extracts demonstrated a serum precipitating factor 
t-dth a titre of 1 In 64. This precipitate was generally visible In 18
to 48 hours* Direct tests for identity and antigen annulment tests were 
th.erefore performed on this serum.
Serum tested undiluted gave 2 and sometimes 3 bands of 
précipitât© with thyrotoxic thyroid extracts and, diluted I in B, only 
one band of precipitate, This serum was therefore compared at both 
concentratione with serum Tra (anti-8 jT), serum Don (antl-8 jD) and serum
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Flu (anti«6jT ^ by the method described on p, 57 using as
antigen a thyrotoxic thyroid gland extract. All 3 bands of precipitate 
produced by undiluted serum Dun crossed the single bands of precipitate 
produced by the other sera (Fig, 12) » at a dilution of 1 in 8 the single 
band of precipitate of serum Dun crossed those of the other 3 sera. The 
precipitating factor in serum is therefore not identical with unti-SJT 
or anti*3 JB.
Annulment of awtiKe.n_t?y_,msan_BHH.
Three volumes of a thyrotoxic thyroid gland extract were mixed with 
one volume of serum Dun and tested, as described (p, 146), with sera 
containing precipitating antibodies anti'-SjT and anti-SJD* The treated 
tiaeue extract no longer reacted with serum Dun but still gave precipitates 
with serum (anti-8JT), serum Dgg (antl-SJD), and serum M g  (anti-8jT f 
anti«8JD). Thyrotoxic thyroid gland extract, treated in the same way with 
either serum T m  or serum Don, reacted with serum Du^,
The results given by these antigen-anmlment tests thus confirm those of 
the direct tests for Identity, showing that the precipitating factor in serum 
Dun is neither anti*SjT nor anti-SJD. Since the patient in whose serum 
this factor was demonstrated was suffering from systemic lupus erythematoaus,
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this factor was designated antt.^ to.p,
0*f* OT^ f EllTi
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noiresia. ïmmunoalectrophorosiB of serum ,Dmi was performed
and the precipitating factor was demonstrated to bave the electropboretlo 
laobllity and pattern of gamm^globulln,.
Qoncluplqn. The precipitating factor in serum Dun appears to be an 
antibody *
UItraceirtrlfumtion* Ultraoenti'lfugation of serum ^  was performed by
Dr. P.A, Gharlwood. None of the resulting fractions, tested in agar-gel 
diffusion testa, gave a precipitate. The fractions were therefore 
concentrated to half their original volume and retested, but once more 
no precipitates were observed with any of these fractions* It is likely 
that the serum factor was too dilute in these fractions, even after 
concentration, to form a precipitate,
Tissue extracts prepared from human spleen, thyroid, adrenal, 
kidney, testis, brain and salivary glands all reacted with serum D ^ $ 
since it is unknown whether the 3 bands of precipitate formed with 
undiluted serum Dug represent 3 antibodies, the serum was used at a 
dilution of 1 in S when only one band of precipitate, probably formed
by a single antlgen-antlbody reaction, occurs. Serum J)un also reacted 
with extracts of lymphatic leukaemie leueocjtee, whereas no reaction was 
observed with extracts of myeloid leukaemio leucocytes. Other exper­
iments with extracts of myeloid and lymphatic leukaemia leucocytes are 
reported on p. 83. Some extracts of washed, normal leucocytes also 
reacted to give a faint band of precipitate with serum but this was 
inconstant, some extracts being negative. Extracts of whole blood, 
platelets, and pooled gamma-globulin did not react with serum Dun.
Extracts of cultured human skin fibroblasts from 4 Individuals (see p. 20) 
reacted to form a band of precipitate with serum Dun. The organs obtained 
from 40 individuals and tested with scrum Dog (p. 63 ) wre also 
tested, Immediately after extraction, with serum Du.vu All those extracts 
reacted to form a precipitate with aeitun ,Dun.
In view of the reported occurrence of antibodies to deoxyribomcleo-* 
protein and to deoxyribonuoloia acid in the sera of some patients with 
systemic lupus erythematosus (e.g. by Oeppallini, Polli and Celada, 1957  ^
Belcher, Hol&ian and Kunkel, 1959)? seTOm fta was tested by the Ou.chterlo^y 
technique with these compounds. Deoxyribonucleoproteln (WP) and
d0oxyribomolei0 acid (DM) ware pared by the method described by 
Mir sky and Polli et or (1946). The crude mcleoprotein at first obtained 
was found, to react with serum Dgm, but when purified by reprecipitation 
and solution, DNP failed to react. Preparations of D M  also failed to
SX
react and neither pxrified DîlF nor DMA annulled the antibody* Histone, 
prepared by the method of Davleon, James, Shooter and Butler (1954), was 
also negative in Onohterlory tests and In annulment tests with anti-Lup*
top in. anlm & l . .
Extracts of liver, kidney and spleen from rabbits, rats, guinea piga 
Incldawce ..&€ anttgen hap .tn anlmaX .ttaswe estmeta.
and mice were prepared from organs taken from freshly killed animals*
Serum Dy^ (diluted 1 in B) reacted with all these extracts* DMA, 
prepared commercially from calf thymus nuclei (Nutritional Bioeberaieals 
Corporation) was tested at dilutions ranging from 12*5 to 500 ug/ml* with 
80mm Dun both undiluted and diluted 1 in 8, but no precipitation was 
obtained, although this rang© of concentrations of DMA was shown to be 
suitable for precipitation with anti-DMA (ae© p* 99 )« This preparation 
of DMA at 500 ug/ml. was also treated with an equal volume of serum 
(diluted 1 in 2) in order to teat whether the serum antibody could be 
annulled by this preparation ? the reactivity of serum Dim was unaffected 
by this treatment* Serum Dun was also tested undiluted with a solution 
containing 25 ug/ml# of commercial DMA which bad been subjected to 
ultrasonic disintegration in an atmosphere of hydrogen - a process which 
disrupts DMA into smaller fragments, more resdl3y diffusible in agar, 
without apparently altering ite immunological roactivity (Seligmann, 
195s)* Mo precipitin reaction was detected between serum Dun and this
preparation* Yeast rlbomtcleic acid (EM) was also tested at a con­
centration of 100 ug/ml* with serwn Dug but no reaction was observed.
elusion. Anti-lap la not an antibody reacting with either BMP or 
DM, This Is supported by the resistance of antigen Lup to treatment 
with deoxyribonuclease (p, 53 ),
Specimens of serum Dun were heated for periods of 30 minutes at 
65%., and 75%, and tested at a dilution of I in 8 with a thyrotoxic 
thyroid gland extract. Heating at 55^0* did not affect the precipitating 
property of serum Dug but the precipitate produced after boating at 65%, 
was rather faint and no precipitate was detected after beating at 75%, 
Specimens of a thyrotoxic thyroid gland extract were heated for 30 
minutes at 37%*, 45%*, 55%#, and 65%# and tested i^ dtb serum Dun" T r y
diluted 1 in 8* A strong precipitin reaction was obtained only with the 
extract heated at 37%,
A thyrotoxic thyroid gland extract, treated with papain at 
concentrations of 0,% and 0,2^ at 37%, for 4 hours, was tested in 
agar-gel diffusion plates with serum Dun diluted I in I6, Antigen Imp 
was weakened t:y 0,1$ papain solution and destroyed by 0,2$ papain solution,
In similar experiments, crystalline trypsin  ^used at concentrations of 
0,4$, 0,%) and 0.1$ destroyed antigen Imp in the thyrotoxic thyroid gland 
extract I chyniotrypsin at a concentration of 0.4$ also destroyed antigen 
lap.
The effect of deoxyribonuclease and rxbonucleasa on an antigen-Lup 
waa determined by treating a thyrotoxic thyroid gland extract with the 
enzymes in the same way as for antigen SjT, described on p.27.
Both the enzymes were without demonstrable effect on antigen Lup.
(Table 10),
In view of the reported occurrence in systemic lupus erythematosus 
of serum antibodies reacting with degradation products of DMA (Stoiler
and Levine, 1961), a solution containing 100 ug/ml. of commercial calf- 
thymus DMA was incubated at 37%# with deoxyribonuclease for 2 hours and 
tested with serum Dun diluted 1 In 8, Bo precipitation was observed.
An extract of lymphatic leukaemia leucocytes, incubated with an 
equal volume of an extract of myeloid loukaamic leucocytes for 6 hours 
at 18%* and tested in an agar-gal diffusion plate with serum Dug, 
produced a much weaker precipitate than the same extract of lymphatic 
loukaemlc leucocytes diluted with an equal volume of saline solution and 
incubated for a similar period. A similar result was obtained with an 
extract of thyrotoxic thyroid extract incubated with an extract of 
myeloid leukaemia leucocytes. Those results suggest that there is in
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Papain
Trypsin
Gbymotrypaln
Biïizyme 
concentration
(S)
0.1
0.2
0.1
0.2
0.4
0,4
Reaction with 
serum Dun 
(1 in 8)
weak
Antigen
treated
with
DNAase
Saline
control
Reaction with 
serum Dun 
(1 in 8)
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extracts of myeloid leucocytes a substance, possibly enzymic, which 
Inhibits the reaction between serum Dug and its corresponding antigen.
Extracts of fresh post-mogtem tissues, including thyroid, adrenal, 
kidney, and surgically-removed thyrotoxic thyroid gland extract, all
fixed complement with serum It%n when tested by the method described on 
p* 149. The complement ".fix! ng titre of serum Dun was approximate ly 1
in 16 with all of these ex trac ts . Complement fixation between human 
tissues and serum from patients with systemic lupus erythematosus has 
been reported by Gajdusek, (1958), Deleter, Holman and Kunkel (i960), 
and llackett, Beech and Forbes (I96O)# Bobbins, Holman, Dei eh or and 
Kunkel (1957), Geppellitii, Polli and Gelada (3.957), Pearson, Craddock 
and Simmons (1958), and Seligmann (1958), a l l  reported complement 
fixation between DMA and serum from some patients td.th systemic lupus 
erythematosus* Accordingly, complement fix a tio n  tests were performed 
between DMA at a concentration of 10 ug/ml* and serum Dun but were 
negative#
The antigen reacting with seruin appears from these resu lts  to  
be present in the tissues of all humans and of all other mammals tested
Since this; antigen occurs in washed leucocytes, it appears to be an 
intracellular constituent. It is present in a crude nude opr ot el n 
complex, but not, in more highly purified BMP, hi stone, or in DMA 
prepared either from human tissue or commercially prepared from animal 
tissue. The antigen is destroyed by the action of certain proteolytic 
enzymes# The limited number of complement fixation tests performed 
suggest that anti-lup may also be demonstrated by this technique.
«3 0 7  «a
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Serum from a patient |1cL was found to precipitate, in agar-gel
diffusion tests, with human tissue extracts, up to a dilution of 1 in 
512, This patient was believed to be a case of systemic lupas 
erythematosus although repeated L.E, cell teats were negative, She
had a transient arthritis and a haemolytio anaemia, as a result of which 
she had received a lumber of blood transfusions. Latterly she developed 
transfusion reactions after receiving matched blood*
The reaction between serum McL and human tissue extract was more•eicRwfl»
rapid, than that occurring with the other serum precipitating factors, 
being visible within 18 hours. When a thyrotoxic thyroid extract was 
titrated in doubling dilutions with serum used at its optimal 
dilution of 1 in 32, the precipitating titra of the extract was 1 in 8 ; 
the serum precipitating factors anti-SjT, anti^SJD and anti«Lup, did not 
generally react with extract diluted more than 1 in 2 or 1 in 4* The 
precipitate occurring with sarum McL was a Undefined band which 
appeared concave towards the serum well. In this respect it resembled 
anti«8JD and differed from anti-8jT and anti-Imp which gave straight 
bands or bands curved towards the antigen well (Fig* 11), Direct tests 
for identity and tests of antigen annulment were performed on serum ^ L*
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Whan sosna» McJ. was o cm pared with serum Tra (anti-SjT), serum Dog 
(antl-SjD)s and serum Dug (anti-tup) the method described on p. 57
reactions of non-id entity were always observed between semm and 
these 3 sera and also with other sera which had been eh m m  to contain 
one or more of these 3 antibodies,
Mine volumes of a thyrotoxic thyroid extract were treated with one 
volume of serum McL as described on p*14.6 and the treated extract was 
then tested with serma Tr§ (anti-8jT), serum Don (anti-8JD), serum P M  
(anti-»SjT -t* anti-3 JB), and serum Dun (anti-Imp) ; treatment with serum MoL 
did not annul the antigen for any of these antibodies, all of which 
reaotod with the treated extract » serum UgL, which reacted with the un­
treated extract, failed to give a precipitate with the treated extract#
The reactions of non-identity of serum McL with other sera 
containing known precipitating antibodies and the results of the 
antigen annulment tests are thus In agreement in showing that serum McL 
contains a precipitating factor different from those previously described.
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Immunoelecti’ophoresis of serum McL, performed
as described on p#147 showed that the precipitating factor bad the 
electrophoretic mobility aiid pattern of gamma-globulln#
U ItracontrIfueat 1 on. yitraoantrifugation of serum MgL was performed by 
Dr* Gharlwood, and the resulting fractions ware tested in agar-gel 
diffusion plates. Bands of precipitate were formed between the tissue 
extract and those fractions which contained the 73 gamina-gloljallns*
The results of immunoeleotrophoresis, ultracentrifugation and antigen 
annulment tests provide strong evidence that the precipitating factor in 
serum McL is an antibody* In the account which follows, it is termed 
antl-McL*
Incidence of nntlKOn MoL In human tissue extracts.
The tissue precipitating antigen for serum McL was shown to be 
present in extracts prepared from human thyroid, kidney, spleen, salivary 
gland, heart, testis and brain. In these tests, senm McL was used at 
Ite optimal dilution of 1 in 32. It appeared however, that this antigen
was either very weak or completely absent from the tissues of certain 
Individuals (Fig* 13). Extracts of organe obtained post-mortem from 4.0 
individuals and tested with serum Dog (p* 63 ) were also tested,
^ go «
immediately after preparation, with aerum Usi>* The tissue extraots 
from 29 Individuals reacted to form a précipitât© with serum MoL. The 
tissue extracts from the remaining 11 iWividuals which gave negative 
results were froeso-dried, reconstituted in water to half their original 
volume, and retested. Po precipitates developed beWeen serum .McL and 
any of these concentrated extracts* although it was shown that an extract 
containing antigen McL could bo concentrated by this technique of freeze* 
drying. One of these concentrated extracts, a thyroid, extract, reacted 
to produce a. band of precipitate with an extract of spleen known to 
contain antigen McL, and when compared with serum McL by a direct Identity 
test (p* 22 ) it was found that the precipitate formed by the concentrated
thyroid metract fused completely with that of serum McL. This thyroid 
extract, oîd.glnally prepared as an antigen, therefore appeared to contain 
antibody Identical to that found in serum McL. This was confirmed by 
testing the thyroid extract with 6 tissue extracts, 3 of which contained 
antigen MoL and 3 of lAich did not contain this antigen, and sbotdng that 
it reacted only with extracts containing antigen MoL. This precipitating 
antibody was also shown to be present in extracts of spleen, heart, Iddnoy 
and brain from the same individuels This patient had died 3 days after 
the excision of a large, malignant rectal polyp and 17 days after 
receiving 2 pints of matched blood# A specimen of blood removed 10 
days after this transfusion could not be shown to contain anti-MoL.
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The patient had a history of previous abdominal operations for paptio 
nicer, and on a previous occasion 9 years before he had been transfused 
with 4 pints of matched blood.
Human serum and plasma from 6 individuals were examined for antigen 
McL but all failed to react with serum MoL# Antigen MeL was detected 
In some extracts of lymphatic leukaemie leucocytes but not in either of 
two extracts of myeloid leukaemio leucocytes from different Individuals.
A reaction between serum and one extract of normal leucocytes was not 
reproducible, and heating the leucocytes of this individual at 56%. In 
an attempt to inhibit possible enzymic changea did not provide an extract 
antigenic for serum McL. The extracts of cultures of skin fibroblasts 
from 4 individuals, which were previously tested with other precipitating 
sera (pp.PO,8o)* did not react with serum McL.
Deoxyribonueleoprotein, prepared in this department by the method 
of Mlrslty and Pollister (1946) from a spleen lAloh had been shown to 
contain antigen McL neither reacted with nor annulled the precipitating 
antibody in serum |icL.
Extracts of liver, kidney, and spleen were prepared from freshly 
killed animals and tested with serum MoL diluted 1 in 32. Hone of these 
organ extracts, obtained from rabbits, rats, guinea pige and mice, reacted
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to form a precipitate with serum MoXu Deoxyrlbonuoleio acid from calf 
thymus nuclei (Nutritional Biocbemicals Corporation) was submitted to 
ultrasonic disintegration in an atmosphere of hydrogen and tested at a 
concentration of 25 ug/ml with serum McL used undiluted. No reaction 
was observed between DMA and serum
Specimens of senim MpL were heated at temperatures of 55%®, 
and 75%# for 30 minutes and tested at a dilution of 1 In 32 in agar-gel 
diffusion plates with a thyrotoxic thyroid extract containing antigen McL* 
Heating at 55%* did not affect the precipitin reaction of serum |M?f 
heating at 65%* diminished the intensity of the precipitate and after 
heating at 75%♦ the serum failed to react to give a precipitate*
By similarly heating portions of a thyrotoxic thyroid extract, its 
antigenicity for serum was found to be unaffected by heating up to
55%*, but was abolished by heating at 65%* and 75%*
The enzyme-treated portions of thyrotoxic thyroid extract, prepared 
as described on p.27 using the enzymes papain, crystalline trypsin,
ohymoti-ypsin* diastase, deoxyrlbonuclease and ribonucleaea respectively, 
were also tested in agar-gel diffusion plates with serum MeL* Extracts
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treated with 0,4$ ohymotrypain failed to react with serum MeL whereas 
treatment with the other enzymea wae without noticeable effect on 
antigen McL, Thyrotoxic thyroid extract incubated with an ogial volume 
of an extract of myeloid leukaemia leucocytes for 3 hours at 37%, and 
at 4%  # overnight still gave a distinct precipitate with serum McL.
Gomplemsnt fixation with serum MqL.
Ooniplement fixation tests were performed by the mathocl cl escribed on 
g,149 using extracts of post-mortem kidney, submandibular gland and
thyroid gland. Scrum McL failed to fix complement with the extracts of 
2 individuals who lacked the tissue precipitating factor reacting with 
this serujn. The extracts of another individual containing antigen McL 
reacted to fix complement with serum |igL at serum dilutions up to 1 in 64.
CassJ^ igisn.
Antigen MoL ie unlike the precipitating factors reacting with 
anti«SjT, anti-SjD and anti-Lup In that it does not ooour in the tissues 
of all individuals tested and was not shown to be present in any of the 
animal tissues tested. The shape of the precipitate, concave towards 
the serum well, and the fact that it appears more quickly than that of 
the other precipitating factors, suggests that antigen McL is a smaller 
molecule, more readily diffusible in agar than antigene S;]T, SJÎ) or Lup.
•-* g/j .—
It was cleteeted in the tissue of 13% (29 out of 40) Individuals. 
Further discussion on the nature of anti «MoL follows the description 
of its detection In the seium of other individuals (pp. 108, 114 )»
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îbe aerum from a patient MgDm vith syatemio la|me erythematosus 
precipitated with human tissue extracts in Ouch ter lony agar-gel 
diffusion plates* The precipitating titra of this serum was only 
1 in 4 but it nevertheless produced a well-defined band of précipitât a 
in 24 to 4S heure which enabled it to be compared with the other factors 
by tests of idcmtity and antigen-annulment teats. Another serum from a 
patient Tan* also with systemic lupus erythematosus, was Investigated at 
the same time as serum McDoii* When tested in an agar-gol diffusion plate, 
serum fm i reacted undiluted to form 2 well-defined bands of precipitate.
At a dilution of 1 in 2j, serum Tap still reacted with tissue extract but 
precipitation was loss than with the undiluted serum and only one band 
was formed, It was possible to use serum Tan undiluted for direct tests 
of identity with other precipitating sera and for antigen annulment tests.
Direct tests
Serum MoDou» diluted 1 in 2 was compared with other precipitating sera, 
using a thyrotoxic thyroid extract as antigen, as described on pp, 22, 57,
The precipitate produced by this serum crossed those of serum Tra (anti-SjT), 
serum (anti-SjD), and serum Dun (anti-Iup), Serum used undiluted,
formed 2 bands of precipitate, which also crossed the precipitates 
formed by anti-S jT, antl-"9jD and anti-Lup. Serum McDou and serum Tan 
formed precipitates which fused completely with each other, suggesting 
that these 2 aera contained the same precipitating factor,
Anrolme»t . of . aagii.m acpQW.
One volume of serum Mc.Oou was used to absorb 2 volumes of a 
thyrotoxic thyroid extract, as described on p, 14.6and this treated 
antigen was tested with antl-SjT, anti-8jD, antl-Wp, and anti-McL, as 
wall as with serum MgDou and serum Tan. The treated antigen reacted 
tclth all these sera except serum McDw and serum Tan*
One volume of serum Tan was mixed with one volume of a thyrotoxic 
thyroid extract and tested as an antigen with. anti-SjT, antl-SjD, anti- 
Lup, and anti-McL and with serum and serum Tan, Neither serum
ËÊË# nor serum Tan reacted with this treated extract but reactions were 
still observed with the other test sera.
When sera containing anti-S jT, anti-8 jD, anti-Dup, and anti-Mob 
were used to absorb thyrotoxic thyroid extract, all the treated extracts 
were found to react with both serum MoDou and serum Tan,•K5SiX9«IT3!K?rpta» ^
The direct identity test and tests of antigen annulment thus show 
that the sera MoDgu and Tan contain a serum precipitating factor which
ma
differs from antl-SjT, anti-SjB, anti-Imp, and antl-McL,
Immnoeleotropb oresls of serum and serum T§n was perfonaed
and the précipitâtIng factor In each serum was shown to have the 
eleetrophoretic mobility and pi^ ttern of gamraa-globulin,
U'ltracentrifmgation was not performed on either of these sera but 
from the results of ImmunoaleatrophorosivS and antigen annulment 
experiments, it is concluded that the precipitating factor present in 
both serca is an antibody*
MsasüL^fesM»
8637um ,!fcl)op, was tested in agar-gel diffusion plates with extracts of 
spleen, normal thyroid, thyrotoxic thyroid or submandibular gland from 
40 individuals* Extracts from 35 Individuals reacted when first tested 
with serum .^nd those from the remaining 5 reacted after they had
been concentrated by freeae-drylng. This antigen was also shown to be 
present in extracts of normal leucocytes, lymphatic leukaemic leucocytes, 
and jïîyeloid leukaemlo leucocytes* Incubation of a thyrotoxic thyroid 
extract with an equal volume of an extract of normal leucocytes or 
myeloid leukaemic leucocytes was performed at 3?%* for 3 hours : these
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mixtures still reacted strongly with serum McDou in a precipitin test
ajj=m-^5MaEMSi-aja a, and serum Tan. :l
fiaiaaiJiâsa^
Serum MsfîSH umil serum Tap were tested with individual extracts of 
liver, kidney and spleen from guinea piga and rabbite and with separately 
pooled extracts of livers, kidneys and spleens from mice* Positive 
reactions were obtained with organ extracts from all these animals.
Reactions acid B wi th _s erum Mt
Tan*
à preparation of dooxyribonucleoprotain (DNP) from an extract of 
human spleen was prepared by the method of Mirskj^  and Pollister (1%6 ) # 
this was tested In an agar^gel diffusion plate with serum McDou and serum 
Tan and was observed to react to form a precipitate with these sera* 
Portions of this DNP preparation were separately treated with 
d0oxyribonueleaso (DNAase) as described by Deioher et al* (1959)^ and 
with rlbomcleaa© (Ellâaea), at 37%, for 2 hours* A control tube 
containing Dip diluted with saline buffered at pR6.(% was similarly 
incubated* These preparations were tested in agar-gel diffusion plates 
l'Æth aorum T^, Treatment with DNAase completely inhibited the 
precipitin reaction of DIP with serum Tan, whereas treatment of DIP
et* 9 9
with EMaae or 'buffered aalln© was without effect (Fig* 14)* This 
GXperlment with BNP was repeated with the same results * Treatment with 
a Op25% solution of crystalline trypsin did not affeot the antigenicity 
of the DNP*
Portions of a thyrotoxic thyroid extract were similarly treated 
with these ensymos* Control tubes containing untreated BNP and 
thyrotoxic thyroid extract were incubated alongside the enzyme-treated 
antigens at 37 0^ * for 2 hours* These antigens were then tested with 
serum Ta^$ Treatment with DNAase destroyed the antigenicity of the 
thyrotoxic thyroid extract but the trypsin-treated extract and the 
controls were still strongly positive* Kitamclease and trypsin 
therefore appear to have no effect on this antigen.
Three volumes of serum Ta^ ware mixed with one volume of commercially 
prepared oa,lf thymus DNA (Nutritional Bioohemleals Corporation) and used 
at a dilution of 100 ug/ml» in water ; 3 volumes of serum Tan were also 
mixed with one volume of yeast ribonucleio acid (RM) at a concentration 
of 100 ug/ml* and both mixtures were kept overnight at 4^0 * These
mixtures were then tested with. BNP* Serum Tan mixed with DM failed to 
react with BNP whereas treatment with ENA had no effect on its precipitin 
reaction with DIP* DMA at a concentration of 100 ug/ml* was tested with 
aerum Tan and formed a precipitate which appeared very close to the 
antigen well* Another portion of this DNA solution was submitted to
iOO
disintegration by sonie vibration in an atmosphere of hydrogen (Sellgmann, 
1958) and then titrated with undiluted serum Tans it now reacted to form 
a wall-defined precipitate approximately midway between serum and DMA- 
containing walls, at concentrations aa low as 6 ug/ml*
IMA was prepared by the method of Kay, Sinmona and Dounoe (1952) 
from spleen taken after death from patient Tan* This DMA was 
rodlssolved in water at a concentration of 100 ug/ml« and subjected to 
sonic disintegration* Both serum Tap and serum McDou reacted to form 
precipitates with this antigen*
These results suggested that the antigen reacting with these sera 
was DMA, 111 order to verify this, a highly purified preparation of 
calf thymus DMA (provided by Dr, Kelr, Blochomletry Department, Glasgow 
University) was submitted to sonic disintegration under hydrogen and 
tested at a concentration of 50 ug/ml with serum Me!)ou and serum Tan, with 
both of which it formed a precipitate. This preparation of purified DMA 
was tested in dilutions ranging from 100 ug/ml, to 1,5 ug/ml, with serum 
Tan and reacted at all concentrations although at 1 ,5 ug/ml* the 
precipitate produced was faint and very close to the antigen well. 
Treatment of the purified DMA at a concentration of 50 ug/ml, with 
deoxyrlbomcloase completely inhibited its precipitin reaction with 
serum McPou and serum Tan,
It is concluded from these results that the tissue precipitating 
factor which reacts with serum MpDpu and serum Tan is DMA,
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Effect, pf beat on antigen for serum Tan,
Speoimena of a thyrotoxic thyroid extract were heated at temperatures 
of 55% . g 65%.g and 75%, for periods of 30 mlmtea. The antigen was 
unaffected by heating at each of these temperatures^ reactions being as 
strong with the heated as with the unheated extract, Specimens of a 
solution of sonio-treated DMA at a concentration of 100 ug/ml,^ heated 
at the above temperatures, were reactive with serum although the 
reaction obtained after heating at 75%, was fainter than with the 
unheated DMA. Highly purified DMA at a concentration of 100 ug/ml, was 
heated In boiling water for 10 minutes before testing in an agar-gel 
diffusion plate with serum McDgu and serum Tans both sera formed ali wedfKRWam# 7
precipitate with this boiled antigen and, as before, this reaction was 
fainter than with the unheated preparation. The temperatures of 75%* or 
higher required to cause impairment of the antigenicity of thyroid tissue 
extract or DMA for the antibodies In serum MgDou and serum Ta^ closely 
approach tluîse at which heat dénaturation of DMA occurs,
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The irmmnological findings in the serum of 4 patients vjitb systemic 
lupus erythematosus have already been desoribed* In 16 other patients 
with this condition, serum precipitating factors to human tissue extracts 
were found g 12 of these factors were sufficiently strong for direct teats 
of Identity and antigen annulment tests to be performed. Sera which 
reacted at 1 in S in the preliminary test ware titrated, using twofold 
dilutions of serum, with thyrotoxic thyroid as antigen*
The serum titres and the results of identity and antigen annulment 
tests are smmarised in Table 11 (p* 104 ).
Among these sera the precipitating factors identified included anti- 
BjTj antl-BjD, anti-Imp and anti-DMA, No other serum was found to 
contain anti-MoL in this series,
All specimens of serum from patients with active systemic lupus 
erythematosus were tested with a solution of calf thymus DBA treated by 
sonic vibration and used at & concentration of 25 ug/ml* In addition 
to the sera 2^1 and M s W ,  (pp.95-101 ), one other serum (seruji la\)) 
reacted undiluted with DMA in this test ? serum Nob also reacted undiluted 
with thyrotoxic thyroid extract. Treatment of the DMA solution w^ith 
deoxyribonuclease (p,100 ) completely inhibited formation of a precipitate 
with serum Nob* Although direct tests of identity and antigen annulment
— X03
tests were not performed on this aeram, these findings suggest that 
serum may also contain precipitating anti-DM,
Three sera (grjo, McMj^ anti Ward) contained precipitating factors 
which, judging hy direct tests for identity and antigen annulment teste, 
differed from those so far described and which have not so far been 
further investigated,
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TABIB 11
Beruïii precipitating factors in 29 cases of systemic lupus
erythematosus
Berua Precipitating
titra
Precipitating 
factors present
Barb 32 anti -^S jD +(? )anti -Lup
Bro 1024 Mot known^
Gam B anti-hup
Dun 64 anti-hup
Glen 16 anti-SjT 4 anti-8jD
hen 64 anti-Lup
Moth 64 anti-f) jD
Mor 16 anti-SjD
McDou 1 anti«DMA
Mob 256 anti-McXi
McMle ' ■ B ' Mot known
Mes 64 anti-SjD f ?
Pea 1 anti-Lup
Tan ! 2 anti-DMA
Hard 1 64 lot known ^
Nob 1 anti-DMA
4 other sera 1 Unidentified
9 other sera m i Mil
These sera contained precipitating factors which differed from 
those previously described,
* The second precipitating factor present in this serum was rather 
weak but it appeared from the results of antigen annulment 
tests that it was possibly anti-Lup,
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tissue diseases oth
The precipitating factors antl-SjT, anti-8jD, anti-tup and 
anti-Hob were also detected among specimens of serum obtained from 
patienta with connective tissue diseases other than systemic lupus 
erythematosus and Sjogren*s syndrome* The results of Ouebterlony agar- 
gel diffusion teats in all the connective tissue disease sera is given 
in Table 12 (p* 109).
Pr(mm8Sim_8Vstaml&_&cl#Tosis_aW de^rmmtqmvositis.
A high incidence of positive results was found in progressive 
systemic sclerosis (9 eases) and dermatomyositia (4 cases), Serum 
precipitating factors were found in the serum of 6 patients with these 
conditions. Multiple specimens of serum were obtained at Intervals of 
9 months to 2 years from 3 patients whose serum contained precipitating 
factors I all these specimens reacted to form precipitates and no marked 
rise or fall in titre was observed,
OomparlBon of the serum precipitating factors with each other and 
with anti-SjT, anti-3 jî), anti «lu p and anti-Mob was possible in 3 oases 
of progressiva systemic sclerosis by direct tests for Identity and 
antigen anmMent tests, (Table 13, p. 109).
No serum was obtained froB\ a tenth patient wltii progressive systemic
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scloroBls, but tissue extracts prepared from organs of this 
individual after death did not react with antl-SjD but reacted with 
extracts of the tissues of other individuals* These findings have 
already been referred to on p.64 where it was concluded that the 
patient®a serum probably contained antl-SjD and that the antigen SjD was 
probably annulled by autologous antibody*
Ghronlo discoid lums erythematosus *
Serum was tested from 14 patients with chronic discoid lupus 
erythematosus, A precipitating factor was detected in the serum of 
one patient but was too weak for direct tests for identity or antigen 
annulment tests to be performed*
Serum from 3 patients with this condition, confirmed by biopsy, was 
tested for precipitating factor to human tissue extracts but none was 
detected *
Active chronic hepatitis associated with a positive cell test
and occurring generally in young women was termed lupoid hepatitis by 
Mackay, Taft and Cowling (1956), Serum was obtained from only one 
patient with this condition and was found to contain a precipitating 
factor of titre 1 In I6, Antigen annulment tests were performed and
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this serum was fourni to contain anti-SJT and anti-8jD, No precipitin 
reaction was obtained between this serum anti a solution of eoinmerclally 
prepared DMA at a concentration of 25 ug/ml which had been subjected to 
ultrasonic disintegration In an atmosphere of hydrogen
Rh eumat aid arthritla
Serum was tested from 114 patients with rheumatoid arthritis and 
in 12 of those precipitating factors to human tissu® extracts worn detected. 
The Bôï*um from 5 patients reacted only when undiluted and in 7 the titre 
was 1 in S or 1 in l6. Direct tests for identity and antigen anmlment 
tests were performed on these 7 more strongly reacting sera and in 5 the 
precipitating factors present were identified as shown in Table 14* (p«110).
Of the two sera which remained unidentified ^ one gave rather faint 
precipitation; the other was from a patient who had severe chronic 
thyroiditis as well as rheumatoid arthritis and whose serum contaim d  
precipitating antibody to thyroglobulin in addition to a precipitating 
factor to extracts of tissues other than thyroid.
The patient Gal, whose serum gave 2 bands of precipitate and 
contained uiiti'-SjT antl#3jD, died, and a splenic extract was prepared. 
This extract reacted to form precipitates tvdth serum Tra (anti-SjT), serum 
Don (anti-.SjD), and serum Gal, the patient * s ante-mortem semxm. In serum 
Gal, therefore, anti-SjT and anti-SjD are to be regarded as auto- 
antibodies since they react with the patient’s own tissue extract.
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(Referred to previously on p, 70, Fig, If? ).
Two patients in this series, McOou and McDla. were found to contain 
the precipitating antibody anti-McL, which has been described in a patient 
with systemic lupus erythematosus (pp,87-94 ). In a serum specimen
obtained from the patient McQou 5 months previously, no precipitating 
factor had been detected • this was confirmed by repeating the tests on 
this specimen with extracts known to contain antigen MoL. This patient 
had been transfused with 2 pints of washed, packed red cello following 
the collection of the first specimen of serum and 20 weeks before 
collection of the second * A history of recent blood transfusions was 
also obtained for patients ifcL and MpDia. It thus appears that anti-McD 
may arise as a result of blood transfusion. (See p* 114 )#
Pranlpltln reactlona hQtween the serum of _ oonneotlve 
tlaaue digeaaea and mrlftocl th-yroglobuMn
All sera in the connective tissue disease series which reacted with 
thyrotoxic thyroid extract were tested with purified thyroglobulin 
solution in order to eliminate the possibility that the precipitin 
roaotion might be a thyroglobulin-antlthyroglobulin reaction, A positive 
result was obtained with the sox’um from one patient with rheumatoid 
arthritis (p,107 ). The results of precipitin tests between Sjogz^ en sera 
and purified thyroglobulin have already been given on pp, 60-61 where it 
was stated that 3 of 48 Sjogren sera contained anti thyroglobulin.
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TABIB 12
Results of agar-gel diffusion tests in connective tissue diseases
Total
Number
Number
Positive
Sjogren’s syndrome 48 15
Systemic lupus erythematosus S9 20
Chronic discoid lupue 
0 xy tihemat osus 14 1
Dermatomyositis and progress­
ive systemic sclerosis 13 6
Rheumatoid arthritis 114 12
P olyarter1ti s nodosa 3 0
Lupoid hepatitis 1 1
TABIE 13
Serum precipitating factors In progressive systemic sclerosis
Serum Precipitating
titre
Precipitating 
factors present
Dev 64 anti-S jD
MeDon 16 anti-lap
Fat 64 anti-SjT 4 
antiwSjD + ?
This serum contained a third unidentified 
precipitating factor which differed from those 
previously described *
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Serum precipitating factors in iteummtoid arthritis
Serum
Fly
Gal
MoGou
McDia
McKnl
Precipitating
titre
B
B
B
16
Precipitating
factors
present
anti-SjT -s- anti-8jD 
anti'4) jT  ^anti-SjB 
antl*44cL 
anti-44cL 
anti-SjD
~  111 -  
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Oonnective tisBue diseases.
Examples of all 4 types of precipitating autoantlbodies (anti- 
S;)l% anti-£>jDj, anti-Imp and anti-DM) described In this Investigation 
were found In patients with systemic lupus erythematosus. The fifth 
precipitating factor, anti-McL, believed to be an isoantibody, was also 
found in a patient with this condition.
Various auto-immune associations have been described in all the 
conditions which have been grouped together as connective tissue diseases. 
The strongest ©vtdence for the occurrence of auto-immunity is in systemic 
lupus erythematosus. The lupus erythematosus (L*E*) factor, described 
by Hargraves (1949) has been shoim to b© an antibody to deoxyribonucleo- 
protein (DMP) of the cell nucleus and antibodies to DMP have been detected 
also by the fluorescent antibody technique (Holman and Kunkal, 1957). The 
incidence of antinuolear factors demonstrated by the fluorescent antibody 
technique is much higher than the incidence of the L.E, cell factor, 
partly because the fluorescent antibody technique is more sensitive in 
detecting antibody to DNP and partly because antibodies to nuclear 
constituents other than BNP are revealed by the fluorescent antibody 
technique but do not produce the L.IS. cell phenomenon (Beck, 1961), 
Antibodies to deoxyribonucleic acid (DMA) have boon demonstrated by
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précipitation and complement fixation (Geppelllnl, Polll and Oelada, 
1957? Robbing, Holtmn, Del cher and Kmikel, 1957, Seligmann, 1958, 
Pearson, Craddock aim! Simmons, 1958, Del cher, Holman and Kimkel, 1959). 
Complement fixing antibodies to histone and crude tissue extracts have 
also been described (iCunkel, Holman and Dei cher, I96O, Gajdusek, 1958), 
and Ashers on, (1959) ? and Dei cher, Holman and Kunkel (1^ 0) described 
reactions with various isolated nuclear and cytoplasmic constituents. 
Complex imtterns of reactivity were obtained between these cellular 
constituents and systemic lupus erythematosus sera, complement fixation 
being obtained not only with nuclear extracts, but in soma eases with 
microsomal, mitochondrial or soluble cytoplasmic constituents.
Patients with systemic lupus erythematosus have also been shown to 
have a proneness to develop organ- or tlsaue-speoific antibodies, e,g, 
to thyroid (Hijmuns, Doniach, Roitt and Holborow, I9S1), rad blood cells 
(4outezidyk and Gear, 1950), leucocytes (Sellgamnn, 1958), platelets, and 
thromboplastin (Dameshek, 1958).
. smtgrnio luuns .ÆvtherMteue.
In the present Investigation, 5 distinct preoxpltating antibodies 
have been detected in the serum of patients with systemic lupus 
erythematosus, It is of in te re s t to eomp\are these precipitating 
antibodies with those described by other investigators.
•*“ 1X3 ™
A ntl-PMA. There is no doubt that antibodies have been demonstrated to
react with DMA (e.g. by Beligmann, 1958, Ceppelllni ©t al., 1957, Robbins 
at al,, 1957, Belcher et al., 1957). This has been further confirmed 
in the present study of serum McDou and serum Tan (pp. 95-101 ). In this 
study it was possible to demonstrate, for the first time, the auto-immune 
nature of antibody to DMA using serum T ^  and DMA prepared fzvm 
autologous tissue,
Anti-Lup, The antibody anti-Lup apparently does not react with D M  or 
purified BMP (pp. 80-82 ). The oorrosponding antigen may be nuclear 
proteiïï other than BMP or a cytoplasmic constituent which has precipitated 
with the crude nuclooprotein preparation found to react with this factor. 
Seligmann (1958) has described a precipitating factor, not anti-DMA, which 
reacts with normal leucooytie extracts. Anti-Lup does not appear to be 
identical with this antibody since it has not regularly been shown to be 
present in extracts of normal leucocytes * (p. 80 ), Evidence that it is 
an auto-antibody rests solely on the fact that antigen Lup has been shown 
to be present in the tissue extracts of all Individuals tested.
Anti-BIT arid anti-5 ID in systemic lunue erythematosus. These auto- 
antibodies have already been discussed on pp. 69-"75 in relation to Sjogren’s 
syndrome. They do not react with normal leucocytes, therefore they are 
apparently different from the anti-leucocyte precipitating factor described by
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Seligmann (195B),
Anti-Mol,. The fifth precipitating factor examined, antl-McL, was 
first found in a case of systemic lupus erythematosus. It also occurred 
in the serum from 2 cases of rheumatoid arthritis and was found to be 
present in the tissue extracts of an individual who had a long history 
of recurring peptic ulceration and who had received blood transfusions 
on at loaat two occasions. This factor differed from the others in that 
it was absent from tissue extracts of 27^ of Individuals tested. 
Accordingly, anti-MeL is considered to be an iso-antibody. It was not 
possible to confirm Its iao-immune nature by testing tissues from the 
individuals whose serum contained the antibody. The development of 
anti-Me L foil wing blood transfusion in one cas© (p, 108) and a history 
of recent transfusions in the others, strongly suggests that it develops 
as a result of blood transfusion. Since antigen Meh was absent from 
30TOm,red blood cells and plasma, it appears likely that the antigen was 
In the transfused leucocytes. In view of the results obtained in tests 
between serum McL and extracts of both myeloid and lymphatic leulmemlc 
leucocytes, the antigen appears to be present in lymphocytes and absent 
from polymorphonuolear leucocytes. It may be that in normal leucocyte 
preparations there were insufficient I^ymphocytas present to give a 
suffiolontJy strong antigenic extract to react with mitl-McL,
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âuto-antibodiQS to cellular tissues bave also been demonstrated in 
other oonneetive tissue diseases by the fluorescent antibody technique 
(Bardawil, Toy, Galina and Bay lea, 1958), and in rheumatoid arthrltig by 
the antiglobulin conaumptlom teat (Steffen, 1959).
Precipitating antibodies to tiesue extracts were also domonstrated 
in this study in the serum of jmtlents with other forms of connective 
tissue disease,
A particularly high incidence of positive résulta was obtained in 
the group with progressive systemic sclerosis In which the s^rum from 5 
of 9 patients possessed precipitating antibodies. This group was also 
examined by the fluorescent antibody technique by Dr, J.8* Beck (1962) 
who found that ,,nuqleolar staining was given by the serum of 2 patients 
with progressive systemic sclerosis. The incidence of this anti- 
nucleolar factor in other forms of connective tissue disease was very low, 
being present in only P patients with Sjogren’s syndrome and In one 
patient with systemic lupus erythematosus in this series.
Of 4 patients with dermatomyosltia, P possessed serum precipitating 
factors but both were weakly reacting and could not be identified, 
Bardawil et al, (1958) detected anti-nuclear factor by the fluorescent 
antibody technique in a case of dermato:yositis.
«* n6 *»
The presence of the rheumatoid (Rose-Waaler) factor in of
patients with rheumatoid, arthritis suggests that an immune mechanism is 
active in this condition. Moreover, 1% of patients with rheumatoid 
arthritis have anti-nuclear factor in their serum (Weir, Holborw and 
Johnson, I9SI). Rheumatoid arthritis Is also a common feature of 
Sjogren’s syndrome, being present in 50-75^ of patients5 depending on 
the diagnostic criteria accepted (Sbearn, I96I). In the present study,
12 of 114 patients with rlieumatoid arthritis were found to possess serum 
precipitating factors, but of these 2 we%*e identified as being of the anti- 
McL type which is considered to be an iso-antibody, in each case arising 
probably as a result of blood transfusion.
In chronic discoid lupus erythematosus there is little evidence of 
auto-antibody formation. Only one patient with this condition was found 
to have a precipitating factor which reacted only weakly and could not 
be identified.
It was of interest to find that the only serum obtained from a 
patient with ’’lupoid hepatitis’’ possessed a serum precipitating factor, 
Gajdusck (1958) reported high titres in A.I.O.F, reactions (see p, 7?) 
with serum from pf.itients with this condition.
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ANTIBODY TO
In the previous sections, antibodies were demonstrated to cellular 
constituents common to a wide range of huji?,an and animal tissues. The 
presence of antibodies to antigens common to various tissues ia well 
established in the connective tissue diseases. In chronic thyroiditis, 
on the other hand, It is eqtzally well eatablisbod that antibodies occur 
which react specifically with constituents of thyroid tiesu©.
There is, however, evidence of overlap in the occurrence of organ- 
specific and non-organ-apeclfic antibcxliee. Thus anti nuclear antibodies, 
frequently found in the serum of patients with systemic lupus erythematosus ? 
have been reported to occur in a proportion of patients with severe chronic 
thyroiditis (#it0, 1959, Holborow? I960, #ite, Bas® and Williams, 1961, 
Hijmans, Doniaoh, Rbitt and Bolborw, I96I) and an increased incidence of 
thyroid«3pacific antibody was reported in patients with systemic lupus 
erythematosus (Hijmans at al., 1^1), and in patients with rheumatoid 
arthritis (Buchanan, Crooks, Alexander, Koutras, Wayne and Gray, I96I). 
There is also evidence of overlap in the occurrence of severe chronic 
thyroiditis and the connective tissue diseases (Bunlm, 1961, Buchanan 
et al., 1^ 61). In the present aeries of patients with eonneetiva tissue 
diseases, 4 sera were found to give a positive precipitin test with
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thyroglobulin, indicating a high concentration of anti-thyroglobulin.
It therefore seemed of interest to determine whether a group of patients 
vd.th various connective tissue diseases showed an increased incidence of 
antibodies to thyroglobulin.
The several known types of thyroid antibodies have been described 
on pp. 7 - 9. They all tend to occur in association with chronic thyrolcL 
it is and the more severe the thyroiditis, the more likely are antibodies 
to be present. They occur in various combinations and If one of them is 
present in high titre, then the others are likely to be present (Balfour, 
Doniaoh, Roitt and Ooucbman, I96I), Of the various tests available, the 
tanned red cell agglutination test for the detection of antithyroglobulin 
is by far the most sensitive and it therefore was used in this 
.investigation.
Of the 223 patients with connective tissue diseases investigated 
in the previous two sections, the serum of 126 was available for 
examination by this technique. These tests were not performed 
eimu-ltaneously, but with each batch of tests positive and negative 
controls were Included and if these were not satisfact033 the results 
were discarded. These results have already been reported (Anderson, 
Goudie, Gray and Buchanan, I96I),
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The test series of patients tiitb connective tissue cliseasea In 
this section included 19 patients with systemic lupus erythematosus,
26 with Sjogren’s syndrome, 13 with chronic discoid lupus erythematosus,
5 with progressive systemic sclerosis, 1 with dermatomyooltis and 62 
with rheumatoid arthritis* The control series, obtained for comparison 
with the group of connective tissue diseases, vas composed of 175 hospital 
patients whose serum had been obtained for blood grouping; this series 
was composed of surgical, medical and gynaecological eases. In neither 
the test series nor the control series vas any patient Included who was 
Imovn to have a history or clinical evidence of thyroid disease ; no 
patient vas excluded from either series, however, because of thyroid 
disease detected in the course of this investigation.
It had been sbovn by Haekett, Beech and Forbes, 1^0, and Hill, I96I, 
using closely similar techniques, that in hospital patients without overt 
thyroid disease, the highest incidenoe of positive results Is found in 
females in the older age groups. Since the test series in the present 
investigation vas composed mainly of females in those age groups, it was 
necessary to choose controls comparable for age and sex with those in the 
teat series in order that the latter would not be biassed by age and sex 
in favour of a higher incidence of positive results. The total number 
in the connective tissue disease aeries vas therefore compared with the 
total number of controls. In addition, the results for each type of
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oonBoetlvQ tiasiia disease were compared with the results in g^ roupg of 
patients from among the controlsj, of comparable age and sox, (Tablee 
15 and 16 ),
The tanned red coll agglutination test for antlthyroglobulln is 
described on pp, 152-154. Since it is known that "purified thyroglobulin 
contains traces of gamma-globulln, the specificity of the reaction was 
determined by porforailng Inhibition teste with "purifiedthyroglobulin 
and gamma-glofoulin„ A description of these teste la given on p* 155.
In the tanned red cell agglutination test, an initial screening teat 
was performed with all the sera at a dilution of 1 in 16, All sera 
positive at this dilution were titrated in fourfold dilutions from 1 in A 
to 1 in AO96 to determine their antithyroglobulin titre.
In these teats 3A (27$) of the patients with connective tissue
diseases and 21 (1% )  of the control series gave a positive result. 
Inhibition tests were performed with these sera and all the sera were 
found to be inhibited by pretreatment with "purified" thyroglobulin| 
pro treatment with gamma-gldbulin did not have any effect on the agglutin­
ation reactions* It was therefore concluded that the reaction was 
specific for antitbyroglobulin. The titres in both teat and control 
series ranged from 16 to over A096j, the titras 1b the connective tissue 
disease series being on the whole higher than in the control series.
Two of the 3 sera from patients with Sjogren®s syndrome which had
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previously been found to contain precipitating antibody to thyroglobulin 
were included in this Berios* Two control sera were also found to 
contain precipitating antitbyroglobulinî there was no clinical evidence 
of overt thyroid disease in these 2 patients.
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Incidence of positive T*R.C, agglutination teats in oonnactiv© 
tiesue diseases and in a control series of comparable age and sex
Total connective 
tissue 
diseases
Total control 
series
Rheumatoid
arthritis
Mo* of oases 
% of oases 
Mo* +ve
Ho, of oases 
% of oases 
Mo, 'î‘ve
Mo, of cases 
$ of cases 
Ho, V©
Controls
Sjdgren® s 
syndrome
Controls
wyawi6B*K<frJia*tiW>niwyiwi.wiFV MFppiw **,
Mo. of oases 
% of cases 
Mo. 4've
Mo, of oases 
of cases
Mo, *fv©
Mo, of cases 
%■ of cases 
Mo, t ve
Mo* of eases 
% of eases 
Mo, 4- ve
Systemic
lupus
erythematosus
Controls
tM^wr»eKiw?Ea>ea^ çj
Chronic discoid
Progressive 
systemic
Dermat orny ositi s
Both
126
fmWMAtwwWpkVJ# u#kW4'%*'UL4*-W*"*
34
175
21
62
15
113
13
26
10
143
19
Mo* of cases 
% of eases 
Ho*  ^ve
Ho, of cases 
Mo* 4' ve
Mo* of cases 
Mo, 4' V8
w>c:wiTOgat!mg»tB^  ^ aaAukamm*MeWK
Ho, of cases
Mo. 4*ve
6
96
9
U
0
Female
26
137
(7ff/j)
18
10
(74%)
11
!
21
(80#)
113
[79
16
17
1
1
3 
1
I
1
>iS îw**K«<»M 'itl«am S.!C im îiaEO Tm iiCTO t-æ 3r»!l¥JBÏC Be»Iit«5W JÏ¥iK»!«l=l!!SSB3»a(KPJSo«a«SS!l^ ^
31
(2^)
(2%)
(26#)
Age
>50
(6%
<51
41
(33;)
47
în?.:
19
48
[77
13
2
30
(21#)
3
2
(10#)
1
12
.2,
1
13
23
(88#)
9
4
0
2
0
10
0
(9%)
19
9
(47$)
4
51
(5S)
7
53,6
>‘,iteSïWESn!*r«iïS*Ra^ «J«îAin»sc3Si:ÆffSK9«î^
2
2
(22%)
0
MKiniikr iw ij"
3
0
1
0
1
3
(12$)
1
(1%)
0
10
(53$)
2
45 
(57$)
10
0
I 4Mïî*%i'^t!rtsïtoateÿ-|
0
0
57.1
55.6
56.1
60,8
61.5
47.2
50.0
42.1
in n
59.0
Sly82
21-89
38-82
30-82
*2Kac#rKsm43iaEaBeî3t5s
38-80
39-89
wawtaamiMEjiBgitrMi™' «>
21-68
21-69
30-60
27-50
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Significance of the Inoreaeecl incidence of positive T*R*C, 
agglutination testa In the connective tissue disease series
Femalessexes
All Over 50
Total connective K- 
tissu© diseases
6.5
<0 <0,01
8.1
<0.01
Systemic lupus 
erythematosus not
significant
not
significant
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In the sei*um of the majority of patients with Hashlmoto’s 
thyroiditis and milder forma of chronic thyroiditis, antibodies have 
been detected which react specifically with thyroglobulin and other 
constituents of thyroid tissue. This la in contrast to the tendency^ 
already referred to (pp. 111-11? ), of patients with connective tissue 
diseases, especially systemic lupu.s erythematosus, to form antibodies to 
various tissue constituents and organs* The present study has also 
demonstrated that patients with connective tissue disease have in their 
serum a higher incidence of antibody to thyroglobu 11 n, as demonstrated 
by the sensitive tanned rad coll agglutination test, than would be 
expected in a group of patients without connective tissue disease and of 
comparable age and sex.
In view of those results, it may be postulated that the development 
of thyroi(3 auto-immunity may occur in one or other of the follcnd.rig ways. 
In thyroid disease, anti-immunity is most frequently directed solely 
against the thyroid gland. The abnormality giving rise to auto-antibcxJy 
formation may therefore be inherent in the thyroid gland or in the 
antibody-pï’cx^ ucing system. If the abnormality Is present in the thyroid 
gland, it is assumed that the antibody-producing system reacts in a 
relatively normal manner to the auto-antigenic constituents of thyroid 
tissue released in the course of thyroid disease. If the abnormality
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is present in the antibcxdy-producing system, it is surprising that 
auto-antibodies to thyroid tissue alone are produced. In the connective 
tissue diseases, however, a range of auto-antibodies with widely 
differing specificities may be detected • it may be assumed that in 
these eonditions the defect lies in the antibody-forming system. A 
discussion of these possibilities in relation to the concept of 
immunological tolerance is given on pp. 129-137,
GENERAL DISCUSSION
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The conditions termed collectively the ’^ connective tissue diseases’’ 
were first grouped together by Klemperer, Pollack aïïJ Baebr (1942). In 
their studies in systemic lupus erythematosus, they observed that the 
common factor to the often widespread involvement of various organs was 
to be found in the pathological changes occurring in the connective 
tissue of these organs. The most characteristic change observed in the 
connective tissues was fibrinoid degeneration. Although these workers 
grouped together rheumatic fever, rheumatoid arthritis, systemic lupus 
erythematosus, progressive systemic sclerosis and datmatoïoyositis under 
the heading of ’’diffuse collagen diseases*% they emphasised that in 
recognising connective .tissue alterations as common to this group of 
conditions, they did not suggest that these diseases were related 
aetiologieally,
There is, hm^ever, evidence of overlap between the clinical and 
pathological features of this group of diseases, which now Includes 
Sjogren’s syndrome (Garde 11 anti Gurling, 1954 ). The literature reporting 
the coexistence of Sjogren’s syndrome td.th systemic lupus erythematosus, 
rheumatoid arthritis, rheumatic fever and scleroderma has been rev1.ewed 
by Shearn (I9S0) and Heaton (1959) has given evidence of the clinical 
and pathological resemblances between Sjogren’s syndrome and systemic
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lupua erythematosus. Rheumatoid factor, a serum factor present in
the majority of patients with rheumatoid arthritis, is present also 
in many patients with Sjogren’s syndrome (Bunim, 19ol) and in some 
patients with systemic lupus erythematosus* it also occurs less 
commonly in other connective tissue diseases. Similarly, the lupus 
erythematosus (L#K# ) cell factor which occurs in the majority of patients 
with untreated systemic lupus erythematosus is also found in a small 
proportion of patients with unequivocal rheumatoid arthritis and in 
other members of the group.
Family studies have been carried out in patients with connective 
tissue diseases t these have fre<|u©ntly been observed to occur in two 
or more members of the same family. Reports of the familial occurrence 
of systemic lupus erythematosus have been reviewed McKuslck fl959) and 
Brun je s, Zike and Julian (1^1), McKuslck has also reviewed the 
literature reporting the familial occurrence of chronic discoid lupus 
erythematosus and rheumatoid arthritis. The familial association of 
different forms of connective tissue disease has also been reported• 
Hagborg, Leonhardt and Skogh (1^1) reported cases of progressive 
systemic sclerosis and systemic lupus erythematosus in one family, and 
Leonhardt (1^1) reported the familial association of progressive systemic 
sclerosis and dermatomyosltis.
Serological studies among asymptomatic releitives of patients with
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connective tissue diseases have also been performed* A high proportion 
of relatives of patients with rheumatoid arthritis have been found to 
possess rheumatoid factor (Ziff, Schmid, Lewis and Tanner, 195B). Anti- 
nuclear factors have also been found to be more prevalent among relatives 
of patients with systemic lupus erythematosus than among patients with 
other eomieotlve tissue diseases (Poliak, Mandema and Kark, 1#0),
Hypergammaglobulinaemia is a common finding in connective tissue diseases 
and Leonhai^t (195?), reporting the occurrence of systemic lupus 
erythematosus in 3 siblings, also observed elevated garama-globulin 
levels in 5 of 11 other siblings of the same family.
The overlap of the clinical and pathological features of the 
connective tissue diseases, already referred to, indicates that they 
share a common aetiological factor* The frequently reported occurrence 
of the various members of this group of diseases within families indicates 
the inf]Luenc© of either genetic or environmental factors. Since there is 
no good evidence of the aetlologioal influence of environmental factors 
and since the diseases have been found to develop in blood relations, 
rather than in spouses (Lam^ene© and Ball 1958), it seems that genetic 
factors are more likely to be concerned.
The immunological associations of the connective tissue diseases 
also show familial occurrence, being found both in the members of a 
family who have a connective tissue disease and also in members without
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the associated clinical features. Assuming that genetic factors are
concerned in the immunological phenomena, they could operate in one or 
both of the following ways.
(a) A genetic abnormality of metabolism might give rise to abnormal 
antigenic breaWown products of cells and tissues.
(b) A genetically determined abnormality In the immnity system 
might permit the production of antibodies which react with normal body 
conetltuents #
In order to discuss this further a consideration of the factors 
concerned in auto-immunlnation is necessary.
Theories of antibody production and immun© response have been 
revolutionised by the concept of immunological tolerance. This concept 
sprang from the work of Owen (1945), who showed that in disygotio twin 
pregnancies in cattle, placental vascular anastomoses linking the 
circulations of the two embryos permitted interchange of the primordial 
blood cells, and that the interchanged cells survived and resulted In
chimeras in which the red blood cells of the twin continued to be
produced alongside the host’s rod blood cells and could be distinguished 
by their different antigenic constitution. In these circumstances, the 
normal inmune response to foreign, homologous red blood cells had
failed to operate and tho adult animal was tolerant to those of its twin.
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The first case of a human chimera was reported by Buosford, Bowley, Hutchison, 
Thom|>son, Sanger and Race (1953) in a single dizygotic twin. Human chimeras 
have since been reported in other eases of dizygotic twins., both of whom were 
still alive, (Booth, Plaut, James, I kin, Moores, Sanger and Baee, 1957, 
Micholas, Jenldns and Marsh, 1957), Reciprocal skin grafting was performed on 
the twins reported by Booth et al, and the grafts behaved as autografts rather 
than homografts sine© they were not rejected by the hosts (Woodruff s%nd Lennox, 
1959)« These dizygotic twins were therefore shown to be tolerant of each other’s 
tissue as well as of each other’s red blood cells,
Billlngbam, Brent and Medawar (1953) showed that immunological tolerance 
could be Induced in foetal or newborn mice by injecting them with living cells 
of mice of a different, histoincompatlbl© strain. They concluded that if the 
immature immunity system of an individual encounters antigens, it not only falls 
to produce a normal, immune response but subsequently the system when mature 
remains incapable of producing antibodies to the particular antigens encountered 
earlier, although it responds normally to other antigens. Immunological 
tolerance cannot readily be induced by antigens which differ widely from the 
normal tissue constituents and such tolerance may be only partial, and may be 
overridden by a subsequent, strong antigenic stimulus (Owen, 1957). It is at 
present believed that immnologieal tolerance is normally acquired to the 
individual’s ovm potentially antigenic tissue and body constituents. This 
accounts for the normal failure of the immnity system to react to autologous 
tissue antigens which are capable of producing immune reactions if injected into 
other Individuals, These observations provided the most important evidence which
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to the development by Burnet (1959) of the clonal selection theory of 
acquired immunity.
The clonal selection theory postulates that in the immature inc1ivJ.dual 
a wide range of potential antibody-producing cells are found, each being 
capable of reacting immunologioally to a single antigen or to a group of 
closely related antigens* The specific reactive capacity of each type of 
cell is considered to be passed on to descendants of the cell. If in the 
immature stag© of development of the Immunity system a potential antibody- 
producing cell encounters its corresponding antigen, it loses, either 
completely or partially, its capacity to produce antibodies against this 
antigen* When the individual’s immunity system is mature, the remaining 
clones of potential antibody-producing cells are capable of multiplying in 
response to their corresponding antigenic stimuli. It is not known h w  the 
encounter with antigen influences the immature inmunity system to bring about 
the state of tolerance* It may be that any clones potentially capable of 
reacting with a particular antigen are rendered incapable of doing so by 
premature encounter with the antigen and that this change in reactivity is 
passed on to their descendants* A second possibility is that the potential 
antlbcdy-producing clones are destroyed by the encounter with their 
corresponding antigens *
Auto-immunization may be regarded as resulting from a failure to 
establish or maintain the state of complete tolerance to one or more
normal body eonstltuenta* On the basis of the olonal selection theoxy, 
there are three possibilities.
(1) Certain antigens may be inaccessible to the immature immunity 
system at the stag© when tolerance is being established. This might 
account for the production of auto-antibodieo to antigenic constituents 
of thyroid, brain, testis, ate*, since at the time when it is believed 
that tolerance is established, these antigene may b© secluded from the 
potential antibody-producing cells or may not yet have developed.
(2) An abnormality may occur in the immature immunity system of the 
individual whereby it may encounter a particular antigen or antigens but 
fail to become fully tolerant towards it or thorn.
(3) Tolerance may be acquired normally but subsequently a mutation may 
occur within the cells of the immunity system whereby the mutant colls 
have lost their tolerance to one or more antigenic body constituents and 
give rise to cells producing antibody which ifd.ll react with normal body 
constituents,
pacifie auto-immune disease wi 
referano© to thyroiditis
Hljmansp Doniach, Eoitt and Holborow (1^1) have divided auto- 
immune diseases into two main groups briefly described as ’’disturbed 
antigen” and ’’disturbed tolerance” diseases, and suggest that between 
these groups exists a range of auto-lmmune disorders which have something
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1b common with each group* Hashimoto’s thyroiditis is considered 
by these worlmrs to be présentât It© of the ’disturbed antigen” 
diseases. The thyroid antigens concerned in Hashimoto’s thyroiditis 
are not normally circulating, and at the time when imrnunologieal 
tolerance in the individual is being established, these antigens are 
assumed to be inaccessible to the potential antibody^-produoing cells 
and thus tolerance is not established. In consequence, if in the 
mature individual the potential antibody-producing cells encounter 
thyroid antigen which has escaped into the circulation as a result of 
disease or Injury to the thyroid glard, they may be stimulated to 
multiply and produce auto-antibodlea specific for thyroid tissue* This 
explanation of the occurrence of auto-lmmunity in Hashimoto*s thyroiditis 
therefore falls within the first of the circumstances postulated above 
for the production of auto-imimnlty. Blagg (I96O) has demonstrated a 
higher Incidence of auto-antibodles in the serum of patients with 
thyroto^ieosis after they have been treated with radioactive iodine, 
suggesting that an autoantigarric stimulus results from the release of 
material from the thyroid gland. On the other hand, Hjort (I96I) 
showed that auto-l^munisation occurred rarely as a result of partial 
thyroidectomy in patients with thyroid disease into whose serum, during 
the few days after operation, thyroglobulin detectable by immunological 
moth ole was being continuously released. More recently, Hjort and
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Pedersen (1^2) have demonstrated "free thyroglobulin" in the serum of 
7 %  of newborn infants and 5(% of their mothers ; thyroid antibodies 
demonstrable in the serum of 3 pregnant women were shown to decrease in 
titre during pregnancy, suggesting an in-vivo antigen-antlbody reaction. 
The higher incidence of "free thyroglobulin" in the infanta* serum appears 
to indicate that it is being secreted from the foetal thyroid into the 
infant’s circulation, crosses the placental bax r^ler into the maternal 
circulation and will react with maternal thyroid antibody, if present* 
These findings cast some doubt on the validity of the "disturbed antigen” 
theory with regard to thyroid disease. Those Infants* sera were tested 
for thyroglobulin only one©, at the time of delivery, but no evidence of 
auto-immunlzation was found in any of 35 mothers whose serum was tested 
6 to 10 weeks after delivery* From these findings Hjort and Pedersen 
think it possible that thyroid auto-immune disease falls into the category 
of "disturbed tolerance" rather than "disturbed antigen" disease. They 
believe that newborn Infants who have free thyroglotmlin in their serum 
have developed tolerance to thyroglobulin and suggest that In those 
infants whose mother’s serum possessed thyroid antibody, a reaction may 
take place between the foetal thyroglobulin and maternal antibody which 
rapidly removes thyroglobulin from the foetal circulation and, in 
comequenoa, tolerance to thyroglobulin may not b© established ? these 
might therefore be the irrfivlduals whose immunity system, when
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challenged thyroglobulin in adult Ilf© (e.g. as a result of pregnancy 
or thyroid disease), reacts to form antibodies to thyroglobulin.
Hall, Owen atrl Smart (I960) have shown that there is an apparent 
genetic predisposition to the formation of thyroid auto-antibodies, but 
Hjort and Pedersen suggest that this may be a "falsa” genetic 
predisposition and may occur In siblings because their mothers possessed 
circulating thyroid antibodies during pregnancy.
Other organ-specific auto-immunities (e.g. to testis, brain) have 
not been so thoroughly investigated as auto-immune thyroiditis and there 
is little direct information to Indicate whether Inaccessibility of 
antigen in the intact individual is concerned.
The occurrence in the connective tissue diseases of a wide rang© 
of antibodies is in marked contrast to that of the thyroid-specific 
antibodies discussed above. The four auto-antibodies which have been 
detected In the present investigation are not organ-specific, reacting 
with extracts of all human cellular tissues examined. Including leucocytes, 
and therefore it la obvious that the corresponding antigens have a wide­
spread distribution in the body. Gonsaqaent3y, it is likely that the 
immature reticuloendothelial system encounters them during the period 
when tolerance is normally acquired. One of the antigens in particular, 
DM, is knovm to be present in all nuclei and its release during the
*»• 136 •*
maturation of erythrocytes alone would be expected to provide opportunity 
for the acquisition of tolerance by the primitive immunity system. If 
these assumptions are correct, then the development of the four auto- 
antibodies could result from:-
(1) failure of the immature immunity system to acquire complete and 
permanent tolerance in spite of the opportunity to do so*
(2) normal acquisition of tolerance but a subsequent development in the
reticuloendothelial system of mutant cells intolerant to the antigens 
concerned,
(3) an acquired metabolic defect whereby abnormal antigenic material is 
presented to the imimnity system which responds by antibody production.
If the first possibility is correct, the immature immunity system 
must fall to acquire complete tolerance to many autologous body 
constituents, for in addition to the antigens concerned in the present 
study, other cell-specific antigens, e,g, in platelets, red blood calls 
and leucocytes, can give rise to auto-immunlty in systemic lupus erythem­
atosus, resulting in thrombocytopanic purpura, haemolytic anaemia and 
leucopania respectively. It seems likely that individuals who eventually 
develop these auto-aatlbodi©B must initially have acquired some degree of 
tolerance, since systemic lupus erythematosus and other conditions 
associated with auto-immunity usually occur in adults*
As regards the second posslbl3i.ty, the proliferation of one mutant
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cell type in the reticulosnclotbelial system would be expected, 
according to the clonal selection theory, to give rise to cells 
producing antibWy which would react with only one antigen or with a 
group of very closely-related antigens* In order to produce the variety 
of auto-antibodies found in the connective tissue diseases, several 
mutant cells would be required to proliferate. This situation, therefore, 
is considered more likely to occur in the multiple mutations concerned in 
lympho-reticular neoplasia than in the connective tissue diseases.
Different explanations have been pat forward by various writers 
(e.g. by Lack, 1961, Potter, I96I) for the mechanism postulated in the 
third possibility. Both these writers, however, suggest that if fre©, 
noxious enzyme should escape into the tissues, it may react to give 
abnormal metabolic products, some of which could behave as auto-antigens* 
If this is correct, then it must be assumed that the four auto-antigens 
described in this study do not normally escape from tissues in-vivo 
except in the presence of the postulated enzyme release. These auto­
antigens cannot be considered to be abnormal since they have been found 
in all normal cellular tissue extracts tested.
These possibilities provide a tentative explanation for the 
occurrence of auto-antibodies in disease. With the exception of the 
antibodies produced against blood constituents, however, circulating
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auto-antlbodles have not been shown to be the oanae of the lesions In 
auto-immune diseases. For example, in various forms of thyroid disease 
auto-antibodies may frequently be detected but only rarely do the thyroid 
lesions progress to give the histological picture of sever© chronic 
thyroiditis (Hoitt and Doniach, I96O)$ the course of systemic lupus 
erythematosus is frequently episodic and this condition may regress 
completely even when auto-antibodies persist In the serum (Leading article, 
Brito Med * J«, I96O). Moreover, the L*E* cell factor has been detected 
in the serum of newborn infants of woman with systemic lupus erythematosus 
and yet the infants have been clinically healthy (Berlyne, Short and 
Vickers, 195?)» In the experimental auto-allergic diseases (thyroiditis, 
encephalomyelitis, etc,,), injection of the antigen combined with Freund’s 
ad juvant gives rise to lesions in the corresponding organ and to 
circulating auto-antibcdles, but in general the extent of the organ 
lesions has not correlated wall with the titre of circulating auto- 
antibody. The experimental auto-allergic diseases do not resemble the 
corresponding human disorders in that they show regression of the disease 
after the action of the antigen incorporated in Freund’s adjuvant has 
declined, whereas in man progressive tissue destruction is a feature of 
the disease. Passive transfer of experimental allergic encephalomyelitis 
has bean performed in rats using lymph node cells from immunized donors 
which were transferred to tolerant hosts (Paterson, i960), aid
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tbyroiditis has also been passively transferred in guinea pigs by the 
same method (Folix-Davies and Halmman, 1^1), Passive transfer 
experiments using serum from immunized animals have not been successful 
in producing the experimental auto-allergic diseases, MoMaster, Lerner 
and Bxum (I96I) studied the relationship of circulating antibody to 
experimental allergic thyroiditis in hiatooompatible guinea pigs and 
found that the antibody titre did not always correlate with the degree 
of thyroiditis, but that all animals with thyroiditis which were skin- 
tested with thyroid extract exhibited delayed hypersensitivity, These 
results indicate that a delayed hypersensitivity mechanism rather than 
circulating antibody, or perhaps a combination of both, is implicated 
in the tissue destruction occurring In the experimental auto-allergic 
diseases. In the present investigation, the auto-antibodies, with the 
possible exception of anti-DM, do not appear to correlate with the 
clinical state of the patient. Anti-DM was found in the serum of only 
3 patients with systemic lupus erythematosus and ? of these have sine© 
died I with such a small number it is not possible to say what 
significance the presence of anti-DM may have on the outcome of the 
disease. The auto-antibodiea anti-8jT, antl-SjD and anti-Iu.p have no 
known clinical or aetlologioal significance, nevertheless their occurrence 
in various members of the connective tissue diseases focuses further 
attention on the clinical and pathological resemblances occurring in these 
conditions and may indicate that very similar mechanisms are operative
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In tbeir pathogenesis*
The observations made in this study raise a number of problems 
and their solution requires much further investigation. Apart from 
DM, none of the auto-antigens have been characterised» prellminairy 
work suggests that this may prove difficult since,the antigens are 
present in very low concentrations in tissue extracts of great chemical 
complexity and are rather unstable, particularly antigen SJD*
The antibodies described may provide useful tools for cytology and 
the antigenie cellular constituents with which they react may be 
concerned not only in auto-immunity, hut also In the important subject 
of homograft immunity.
In addition to the auto-antibodiea which have been described, other 
serum precipitating factors have been detected but remain to be 
investigated and it seems certain that a large number of precipitating 
factors will eventually be demonstrated,
M'ffiEIAIS AND I®TH0D3
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Specimens of clotted blood were provided by clinicians of the 
Western Inflrmaiy, Glasgow, and several other hospitals, from patients 
with various eonmctiv© tissue diseases In whom the diagnosis had been 
reasonably established* The serum was pipetted from these specimens, 
centrifuged to remove red blood cells, then stored at -20%* until 
required for use* Serum obtained for blood grouping and cross-matching 
was also provided by the Haematology Department, Western Infirmary, from 
hospital patients with various surgical and medical conditions, but with 
no clinical history of symptoms of connective tissue diseases » serum 
from this group of patients served as controls*
Tissue extracts.
Human tissues were generally obtained a few hours after death, or, 
as in the case of thyrotoxic thyroid gland, war© removed surgically* 
Animal tissues were removed immediately after death*
Tissue extracts of thyroid, liver, sp3.a©n, etc., were prepared hy 
mincing the organ, then homogenising in an M*S*B* homogeniser for 3 
minutes at full speed with an equal volume of 0*9|; sodium chloride 
solution (saline solution) containing one fifth volume of isotonie 
phosphate buffer of pH 7,5* The tissue homogemt© was then centrifuged
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at 2000 g* for 30 minutes and the supernate was removed and stored 
undiluted at -20%* until required for use. The preparation of tissu© 
extracts was carried out at 0-5%« throughout,
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Twenty ml. of venous blood from normal individuals or leukaemio 
patients was taken into 2 ml. of a 1*5^  solution of disodlum ethylene 
dimiine tetra-acetic acid (E.D.T.A.) as anticoagulant and mixed gently 
by inversion of the container. 4 ml. of a 6% solution of d ext ran in 0.%
saline solution was mixed with the blood » the mixture was allowed to
sediment for 45 minutes and the leucocyte-rich plasma was carefully 
removed by pipette. Up to this stage the method used was essentially 
that described by Waiford (I96O). The leucocytes were deposited by 
centrifugation at 900 g. for 15 minutes, washed three times in 0.9gl 
saline solution buffered at pH 7.5, and resusponded in an equal volume 
of saline solution. The leucocytes were then disrupted by thrice 
freezing at -20%. and thawing. After this treatment the material was 
used as antigen, without further centrifugation, in Ouehterlony agar-gel 
diffusion tests.
In the first instance, the sera for investigation were tested for
antibody to tissue constituents by a technique of double diffusion in an
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agar gel (Ouchterloï^  ^ 1953). Antigen and antibody are placed in 
separata wells in the gel and allowed to diffnse Into the gel; 
precipitating antibody, if present In the serum, diffuses from the 
serum well and encounters antigen, diffusing from the tissue extract 
wellI where the relative proportions of antigen and antibody permit, 
a band of precipitate is formed in the gel*
%cnT,erionv Gectiro
miration of agar plates* It was found that a 1#?^ concentration 
of Bifco *Bacto* agar in 0*% salin© solution gave a reasonably clear gel* 
Sodium aaida, at a final concentration of 0*11 was added to the melted 
agar to prevent bacterial i^owth and.20 ml* of this agar was poured into 
a 9 cm* diameter petrl dish and allowed to set* In order to provide 
wells for the serum and antigen extract, holes were cut in the agar by 
means of cork-borors* Preliminary tests were performed loy placing serum 
and tissue extract in wells of 6 mm. diameter with centres 12 mm* apart, 
but it was subsequently found that the sensitivity of the test was 
increased by using larger wells, of 10 mm. diameter, with centres 15 mm* 
apart; one was filled with tissue extract and the other ié,%h serum* The 
positioning of the walls was first of all marked on graph paper, which 
was then placed below the petrl dish to act as a guide when cutting the 
wells. The agar discs thus punched out were removed by suction pipette*
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For routine testing of the serum for precipitating factors, the 
serum was placed in wells diametrically opposite on either side of the 
antigen well* the serum was used undiluted in one well and diluted 1 In 
8 in the other ; the latter serum dilution was used since it sometimes 
happened that undiluted seiiam containing a high antibody concentration 
produced a precipitate %Aich appeared so close to the antigen well that 
it was obscured by the opaque sons surrounding this well* at a dilution 
of 1 in Bp however, the precipitate appeared in the clear zom between 
the tissue extract and oej’um wells* The patri dishes were kept 
uncovered for a few hours after the wo 11s had been filled, since it was 
found that diffusion of the reagents through the gel was hastened when 
evaporation also took place from the suî^ faee of the gel* A positive 
result showed as one or more white bands of precipitate in the agar 
developing within 72 hours, usually within %  hours.
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Staining technique for protein preclpltatecl In a^arr#
Occasionally It was desirable to wash the excess protein from a plate 
containing a weakly positive preoipitin teat and to stain the precipitate 
remaining in the agar-gel with a protein-specific dye, naphthalene black. 
After this treatment the result was more easily read ? these testa could 
also be preserved for reference, since photography of weakly positive 
r©3u3„ta was difficult.
Pr©iiaimtion of dvé sdlution. The solvent consisted of a mixture of 
methyl alcohol, distil3.ed water and acetic acid in the ratio 50?50810 
by volume* A saturated solution of naphthalene black lOB (G,T« Gurr, 
Ltd.) was prepared in this solvent.
Method. The agar plate was washed for at least 24 hours in several 
changes of saline solution and rinsed in water for 3.0 minutes to remove 
most of the salt ; the agar gal was carefully transferred to a glass 
slide of suitable sise and dried on to the slide by beating in m  
incubator for a few hours at 3?%. The slide was then imnersed in 
the dye solution for approximately 30 minutes and washed in 3 changes 
of fresh solvent until all traces of diffuse staining of the agar were 
removed, the slide was then rinsed in water, dried at room temperature 
arâ preserved by painting with a coating of clear varnish {^Brcalon©*, 
Canning and Go.)
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The precipitating factors in positive sera were compared 
by means of treatment of the tissue extract or constituent with a 
precipitating serum to annul the corresponding antigen. The tissue 
extract thus annulled for one type of precipitating serum continues to 
act as antigen with other sera containing precipitating antibodies 
directed against other tissue constituents which remain unblocked* 
Precipitating sera containing the same type of antibody as the serum 
used to treat the tissue extract also fail to react with the annulled 
tissue extract.
Technique. Tissue extract was mixed with serum containing a precipitating
antibody of titre exceeding 1 in 64 in the ratio of 9 parts of extract to 
on© part of serum ; a correspondingly higher proportion of serum was 
mixed with the extract if the titre of the precipitating antibody was 
1 In 64 or less. The tissue-extraot-serum mixtures wore kept at 4^0. 
for 18 hours to allow annu3üient of antigen and were then tested as 
antigens against various precipitating sera by the agar-gel diffusion 
technique. The serum used to treat the tissue extract was also tested 
and a negative result with this serum indicated that the corresponding 
antigen had been annulled. In controls performed simultaneously, the 
same sera were tested with the tissue extract treated with normal serum
- 147 -
to ensure that treatment of the extract with normal serum had not 
abolished the reactivity of the extract in precipitin tests.
îmïiiuno©leetropiî,or©Bi3 in agar was performed by a micro-technique 
described by Goudie (1%0), By electrophoreais of the serum containing 
precipitating factor to human tissue extract, the fraction of serum 
containing the precipitating factor may he identified by placing a trough 
containing the tissue extract alongside the electrophoretic run and 
observing the position at which a band of precipitate is formed and 
comparing it with the bands produced between the serim and rabbit anti­
human serum (Ooombs reagent).
Borate buffer. Boric acid 2 4 # 8 1 g ,/litre  (0,4 M,)
S cd ium borate Ba^^O^lOH ^0,38,22g ./litre (O. IM, ) 
These solutions were mixed In the proportion of 675 ml* 0,4 M. boric 
acid to 300 ml, 0,1 M, sodium borate and distilled water was added to a 
total volume of one litre* the pli of this Wffer was 8.1,
Difco *Bacto® agar was dissolved in borate buffer to a concentration 
of 1,71 and the melted agar was poured on to glass slides 8,25 cm, square 
which had been coated previously with 0,3$ agar in distilled water and
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dried in air* coating with a thin layer of dilute agar provided a 
better surface for adhesion of the thicker layer of agar gel (2,5 mm, 
approx). When the agar had set, a well 4 mm, in diameter was cut in
the agar; troughs^ 4 mm, in width and 7 era, long were out in the agar 
on either side of the well and in the game direction as the eleotro- 
phoretic run would take place, (See fig, 4)«
The serum for electrophoresis was placed in the well and 
©lectrophoresis was carried out for 2 hours at 110 volts (current 
approximately 20 milliamps,) for good separation of serum proteins 
id.th little rise in temperature* The troughs were then filled with 
tissue extract (or rabbit anti-human serum) and the plates were kept in 
a moist atmosphere© at room temperature, inspected daily for 4 daysg ard 
the results recorded. Finally, the plates war© washed and stained W.th 
naphthalene black as described on p* 145.
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Sera. The sera to be tested were heated in a water-bath at 56^0, 
for 30,minutes immediate3y before use to inactivate complement,
Complément. The source of complement was fresh guinea pig serum which 
was stored at -20^G, until required for use.
Indicator, for comp3.oment. A 3$ suspension of sheep red blood cells 
sensitised with 4 minimum haemolytic doses (4M,H,D, ) of an immune serum 
from a horse injected t^ lth sheep cells (supplied by Burroughs Wellcome 
and Go.) was used as the indicator for the detection of complement*
Titration of complement. Complement was titrated each day immediately 
before use, A 1 in 5 dilution of complement was made and 0*5 ml* of 
sensitised sheep cells was added to a row of tubes (7,6 x 1*25 cm.) 
containing 0*025, 0*03, 0*035, 0.04, 0*045, 0.05 and 0.055 ml, of 
oomploment dilution respectively; the tubes were incubated in a water 
bath at 37^0. for one hour* The smallest volume of guinea pig 
complement giving complete haemolysis of the sensitised cells was taken 
as 1 M.H.D, of complement*
Antimns. The tissue extracts used as antigens in the complement 
fixation tests were prepared in the same manner as for the Ouehterlony 
technique. Twofold dilutions of the extracts from 1 in 1 to 1 in 8
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were tested for antieomplementary activity using 2 M.H.D, of complement 
in each tub© and incubating the tubes at 37%, for one hour before 
adding 0,5 ml, of sensitised cells and incubating for a further hour 
at 37%, 0ach extract was used in the test at the highest 
concentration at tfhieh no antloomplementary activity was observed, i,e* 
the highest concentration at which they did not fix more than 1 M.H.D, 
of complement. When sera had been found which fixed complement with 
extracts of this type, these sera were used to determine the effective­
ness as antigens of fresh tissue extracts ; sera of knotm titre were also 
included with each batch of tests as a check on the oontiming potency of 
the antigenic extracts.
Test. The test for complement-fixing antibodies in serum was set up 
as follows.
For each serum to be investigated, 0,1 ml, volumes of undiluted 
serum and serum cîiluted 1 in 4 were used • 0,1 ml, of antigen dilution
and 0,1 ml, of complement containing 3 was added to each tube
containing serum. Anti complementary controls for each serum and for 
the antigen used in the test were also included | these consisted of 
0,1 ml, volmies of sgtoe or antigen dilution and 0,1 ml, of diluted 
guinea pig serum containing 2 M.H.D, The tubes were shaken to mix the 
contents and incubated at 37^0 for one hour with occasional shaldng,
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after which 0,5 ml, of sensitised cells were added to each tube. The 
contents of the tubes were again mixed and allowed to remain at 37%, for 
a further hour, and the results were read visually according to the amount 
of lysis in each tube. Complete lysis in the 2 control tubes indicated 
that neither serum nor antigen alone had an anti complément ary activity of 
more than 1 ; accordingly, partial or complete inhibition of lysis
in the test, using 3 M,B,D, of complement, was not attrlbu.tabl© to the 
sum of the antieomplementary activities of serum and antigen. Any 
slight inhibition of lyeis occurring in the test id.th the undiluted 
serum was regarded as an equivocal (t) reaction* marked inhibition of 
lysis in the test containing undiluted serum was termed weakly positive (+) 
sera giving partial or complete inhibition of lysis in both the test 
containing undiluted serum and that containing the serum diluted 1 in 4 
were termed strongly positive complement fixing sera Positive
results were accepted as indicating the presence or absence of antibody 
only when complet© lysis occurred in the serum and antigen anticomplement­
ary control tubes.
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Red Blood Cells a Group 0 human bloody obtained by finger prick, was 
collected into a solution of five parts of 0*% saline solution and on© 
part of 3.8$ sodium citrate.
Buffered Sa.IIn© t This was a solution of 0.9^ saline solution containing 
on© part per hundred of M/15 phosphate buffer, pH7.2.
Tannic Acid s A stock solution of 0.5$ tannic acid in cl 1 stilled water 
was made up freshly each week and kept at 4%. B"or use, this solution 
was diluted in buffered saline to a final concentration of Is15,000. 
Antigens Purified thyroglobulin, prepared by the rnetbcscl of Berrien 
et al, (1948), was used at a concentration of 2mg. /ml. in buffered 
saline. According to Witebsky and Rose (1956), tanned red cells coated 
with thyroglobulin are agglutinated more strongly by anti*>thyroglobulin 
if the solution of thyroglobulin used to coat the tanned colls Is 
previously immersed in a boiling water bath for 2 minutes. In practice, 
it was found that agglutination ijas considerably enhanced by this 
procedure and the antigen was always treated In this way, and coaled 
to rooBi temperature before mixing with the '^tannedred blood cells.
Sera g The sera were inactivated by beating at 56%, for 30 minutes 
before use.
Normal Babbit Serum g This was inactivated by boating in a water bath
~ 153 ~
at 56%# for 30 minutes, absorbed twice with an equal volume of washed, 
packed human group 0 HBOs, and stored at -15%. A solution of buffered 
saline containing on© part per hundred of normal rabbit sorum (HFiS) was 
used to wash and resuspend the tanned, coated red cells (THG), 
Premrati^n_of^anned_rM blogcl cellg ? Human i^ ed blood cells (RBGs), 
thrice washed In buffered saline then re suspended to 4$ were added to an 
equal volume of the 1:15,000 tannic acid solution. After 30 minutes at 
room temperature, the "tannedHBOs were centrifuged gently, washed once 
with buffered saline and resuspended to give a %  suspension in buffered 
saline. The cells were then mixed with an equal volume of antigen 
(thyroglobulin) solution in buffered saline, kept at room temperature 
for 45 minutes, centrifuged gently, washed twice in buffered saline 
containing 1 in 100 RRS and re suspended to give a 1$ suspension of cells 
in buffered saline containing 1 in 100 MS. Meanwhile, fourfold 
dilutions of the sera to be tested had beeli made In buffered saline and 
one drop of each dilution was placed in a narrow polystyrene tube 
(3*8 % 0'„5 cms#). An equal volume of 1$ TECs was added to each tube*
The tubes were then shaken to mix the contents and allowed to remain at 
room temperature for 1-2 hours* A positive result showed an even 
carpet of calls widely spread over the curved base of the tube, a 
corner of the carpet sometimes being rolled inwards if the cells were 
strongly agglutinated. If no agglutination had occurred, the cells
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settled in a small button at the base of the tube. The results were 
most easily read in a good light, using a hand lens, by viewing the 
tubes from below and taking great oare not to agitate the contents, 
(Fig. 16)
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Since it is known that the * purified* thyroglobulin used to coat 
the tanned red cells in these teats contains small amounts of serum 
gamma-globullns and other proteins, inhibition tests were performed on 
all sera found to be positive by the tanned red cell agglutination test 
in order to determine whether this test was specific for thyroglobulin. 
The Inhibition tests were performed by treating duplicate dilutions of a 
positive serum with thyroglobulin and with gamma-globulin, followed by 
addition of the thyroglobulin-coated tanned red colls.
The thyroglobulin preparation used to coat the tanned red cells 
was also used in the Inhibition tests; the gamma-globulin was pooled 
serum gamma^-globulin (prepared by the Scottish National Blood Transfusion 
Service). It was found that a solution of gamma-globulin containing 
2 mg./ml. x’egularly agglutinated TEOs * this is thought to bo due to the 
presence of a low concentration of antibody to thyroglobulin in the serum 
of some individuals without clinical evidence of thyroid disease. 
Accordingly, both gamma-globulin and thyroglobulin were used in 
inhibition tests at a concentration of 0,5 mg./ml., at which no 
agglutination occurred.
Inhibition tests were performed on positive sera which bad been 
diluted 1 in 2 to 1 in 3.6 (depending on the TEG titre of the sorum).
One drop volumes of the serum dilution were separately mixed with one
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drop of thyroglobulin solution, one drop of gamma-globulin solution, 
and one drop of buffered saline as control* To each mixture was added 
one drop of tanned, coated red cells and each was mixed again and 
allowed to remain at room temperature for 1 - 2  hours before reading 
the results,
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Preparation of radioactive labelled antigen or antibody
The method of labelling of protein is essentially that described 
by Francisj Mulligan and Wormall (1954)»
An excess of iodine was shaken in 25 ml, of O.OIM potassium iodide 
solution on a shaking machine for a few hours at room temperature. The 
amount of iodine which had dissolved in this solution was estimated by 
titration of a portion of the filtered solution with 0,011 soliim 
thiosulphate solution. For every 100 mg. (approximately) of protein in 
the solution to be labelled, 3 mg. of free iodine was required. 
Accordingly, a volume of iodine-iodide solution containing the required 
amount of free iodine was added to a solution containing 1 millicurie 
15 ml, of a fresh thyrotoxic thyroid gland extract, which had been 
centrifuged tt^ de© at 34-000 g, for 30 minutes, was made alkaline with 
1.5 ml, of 5N ammonia and the radioactive solution was added, drop by 
drop. The solution was allowed to stand for a few minutes while 
iodination was completed and the solution then adjusted to pH 7,3 
with 2M, acetic acid. Any remaining uncombined with protein in
this solution was removed by passing the solution through an *Amberlite® 
column,
A similar procedure was followed to prepare labelled serum.
o
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Precipitate formed between serum from a patient with 
Sjogren’s syndrome (serum Tra in well on right) and 
an extract of parotid gland (centre well). The other 
wells contain non-reacting serum, (x 7)
%(
' M
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Fig. ?■
Twofold dilutions of Sjogren oyndreme (upper and lower 
wells) and an extract of human liver (centre wells). The 
precipitates produced are obscured by the dense zones of 
opacity round the tissue extract wells but can be seen 
with the first three serum dilutions. The apparent 
diminution in the opacity round the tissue extract wells 
towards the right of the photograph is due to a lighting 
effect and not to dilution of the antigen extract (x 1)
mk
Fig:. 3A
Twofold dilutions of serum Tra reacting with an extract 
of thyrotoxic thyroid gland. The initial dilution 
(upper left well) is 1 in 2 and increasing dilutions 
are placed from left to right along the upper and 
lower rows. Undiluted tissue extract is in the centre 
row. Reactions are visible up to a serum dilution of 
1 in 64. ( X 1)
%32. '/fotf y12%
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This is the same plate as 3A after staining with 
naphthalene black. Removal of excess protein 
from the plate by washing and subsequent staining 
of the precipitate has made it possible to see 
that serum Tra reacts up to a dilution of 1 in 256. 
The reactions of serum Tra at higher dilutions 
are clearly complex and a second antibody, visible 
only in the stained plate, may be present, (x 1)
rig. 4
Immunoelectroï^oresls of serum Tra (right well). 
Immunoelectrophoresis of a serum containing 
thyroglobulin precipitin, present in the gamma­
globulin serum fraction is also shown (left well) 
The factor in serum Tra reacting with thyrotoxic 
thyroid extract therefore corresponds electro- 
phoretical3y to gamma-globulin. (The antigen 
reacting with the thyroglobulin precipitin is in 
excess and the precipitate formed has migrated, 
appearing broad and fuzzy), (x 1^)
â
Fig. 5
Reaction of identity of the precipitates formed 
with serum Tra (small well) and in extracts of 
thyrotoxic thyroid gland (large well, left) and 
lymphatic leukaemic leucocytes (large well, 
right), (x 2)
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Serum Scr is in the upper left veil undiluted, 
forming 3 bands of precipitate with an extract of 
thyrotoxic thyroid gland (centre); in the lover 
left well is serum Scr diluted 1 in 8. The 
right hand wells contain a negative serum at the 
same concentrations as serum Scr. (x 2)
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Fie. IQ A
Arrangement of veils for a direct 
test for identity of precipitating 
factors in Sjogren sera. The 
centre veil A contains the tissue 
extract and on opposite sides of 
this veil B, C and D on one side 
and F and G on the other contain 
the precipitating sera, vhich are 
used at an optimal dilution for 
the size of well and distance from 
the central antigen veil.
Fie. 10 B
A direct test for identity of 
precipitating factors in Sjogren sera.
Well A contains thyrotoxic thyroid gland 
extract. Well B contains anti-SjT vhich 
forms a "reaction of non-identity" with 
both anti-SjD sera in wells C and D; wells 
E and F contain sera whose precipitating 
factors are both anti-SjD forming pre­
cipitates giving a "reaction of identity" 
whereas well G contains anti-SjT vhich 
forms a "reaction of non-identity" with 
the serum in well E, (x 1)
Fig, 11
Appearance of precipitates formed by anti-SjD, anti-McL 
and anti-Lap with an extract of thyrotoxic thyroid gland. 
Serum Dun (anti-Lup) is on the left and here forms Î? 
bands of precipitate; the upper well contains serum Don 
(anti-SjD) and serum McL (anti-MeL) is on the right, 
both anti-SjD and anti-McL form precipitates which are 
concave towards the serum well. The lower well contains 
a negative serum, (x 2,5)
Fie. 12
Reaction of non-identity given by undiluted 
serum Dun (small veils on left) and serum Plu- 
containing anti-SjT ♦ anti-SjD, diluted 1 in 4 
in upper large well and 1 in 16 in lower large 
well. The small wells on the right contain 
serum Dun diluted 1 in 8 but insufficient 
antibody is present to form a distinct
precipitate visible in a photograph, (x ?)
FlKt 13
Serum Met (centre well) with k thyrotoxic 
thyroid gland extracts. Well defined 
precipitin reactions are seen with 3 
extracts but there is no reaction with 
the fourth (lower well), (x 1)
' ) (.)
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Fig. U
Two preparations of DNP from human spleen tested 
with serum Tan (centre weIls\  Extreme left and 
right wells contain untreated DNP, upper wells 
contain DNP preparations treated with deoxyribo­
nuclease, and lower wells contain DNP preparations 
treated with ribonuclease, The reaction is abolished 
by treating the preparation of DNP with deoxyribo­
nuclease tut not by treatment with ribonuclease.
(x 1),
rig,.,-IS
Plate stained with naphthalene black 
showing splenic extract from patient 
Gal (centre well) reacting with serum 
Tra (upper well) containing anti-SjT 
serum Don (lower well) containing 
anti-SjD and autologous serum Gal (left) 
containing both anti-SjT and anti-SjD,
(x 1)
D iagram m atic  representation of tanned red  c e ll agglutination.
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Diagrammatic representation of positive and negative 
agglutination of tanned red cells, coated with 
thyroglobuli n,
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